mitomycin has been researched along with Cancer of Lung in 530 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the efficacy and safety of oral Uracil/tegafur (UFT) with leucovorin and mitomycin C (MMC) as third-line treatment for patients with extensively pretreated metastatic colorectal cancer (mCRC)." | 9.16 | Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study. ( Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D, 2012) |
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 9.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "Between October 1986 and June 1997, 39 patients with advanced inoperable malignant mesothelioma were treated with palliative MVP (mitomycin-C 8 mg/m2 q." | 9.08 | Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma. ( Ashley, S; Hickish, T; Middleton, GW; Norton, A; O'Brien, ME; Priest, K; Smith, IE; Spencer, L, 1998) |
| "A prospective randomized study to compare the effectiveness of pleurodesis by two new sclerosing agents: OK-432 and mitomycin C were conducted in 53 patients with malignant pleural effusion caused by lung cancer." | 9.07 | Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. ( Chang, DB; Kuo, SH; Lee, LN; Luh, KT; Yang, PC; Yu, CJ, 1992) |
| "Fifty patients with inoperable adenocarcinoma of the lung were randomized in a prospective study to receive either standard doses or high doses of 5-fluorouracil, adriamycin, and mitomycin-C (FAM versus Hi-FAM)." | 9.06 | 5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules. ( Ip, M; Kung, TM; Lam, WK; Sham, MK; So, SY, 1987) |
| "To evaluate the clinical efficacy and safety of mitomycin C in the local control of malignant pericardial effusion, we carried out a trial of pericardial drainage with local instillation of mitomycin C in eight patients who suffered from cardiac tamponade or symptomatic large pericardial effusion caused by advanced non-small cell lung cancer." | 7.73 | Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer. ( Horie, T; Imai, H; Inazawa, M; Kaira, K; Kobayashi, G; Mori, M; Mori, T; Takise, A; Utsugi, M, 2005) |
| "Twenty patients with malignant pericardial effusion were treated by ultrasound guided pericardiocentesis and the intrapericardial instillation of mitomycin C." | 7.69 | Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion. ( Chang, DB; Ko, JC; Lee, LN; Liaw, YS; Luh, KT; Wu, RG; Yang, PC; Yu, CJ, 1994) |
| "Two cases of recurrent breast cancer, for which combined therapy using toremifene and oral chemotherapeutic agents were effective, are reported." | 7.69 | [Complete tumor regression obtained by chemoendocrine therapy including toremifene in two cases of pulmonary metastasis of breast cancer with a history of tamoxifen treatment]. ( Asanuma, F; Miyagawa, T; Toyoda, H; Uesato, K; Yamada, Y, 1997) |
| "We developed a mitomycin C (MMC)-resistant human lung adenocarcinoma cell subline, SPC-A1/DM4, from cloned SPC-A1/D13 parent cells by 1 h exposures to escalating concentrations of the drug over 17 months." | 7.68 | Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance. ( Dong, QG; Gong, LL; Wang, EZ; Wang, HJ, 1993) |
| "To evaluate the efficacy of a combined therapy of prednisolone and alprazolam for controlling cisplatin-induced delayed emesis, a study involving 14 non-small cell lung cancer patients receiving cisplatin (80 mg/m2) was conducted." | 7.68 | [A combined anti-emesis therapy of oral prednisolone and alprazolam for cisplatin-induced delayed emesis]. ( Horio, Y; Iwahara, T; Minami, H; Sakai, S; Shibagaki, T; Shimokata, K; Watanabe, A, 1990) |
| "Twenty-six patients with advanced bronchogenic adenocarcinoma or large cell carcinoma were treated by combination chemotherapy consisting of Ftorafur, adriamycin and mitomycin C (FAM II)." | 7.67 | Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma. ( Cruciani, AR; De Marinis, A; Nunziati, F; Portalone, L; Salvati, F, 1984) |
| "The disposition kinetics of the cancer chemotherapeutic agent mitomycin C have been studied in six male patients receiving mitomycin C in combination with cisplatin and vinblastine for non-oat cell carcinoma of the lung." | 7.67 | Pharmacokinetics of mitomycin C in non-oat cell carcinoma of the lung. ( Buice, RG; Gurley, BJ; Niell, HB; Sidhu, P, 1984) |
| "Nineteen patients with adenocarcinoma of unknown primary were treated with the m-FAM regimen, consisting of methotrexate 50 mg/m2 days 0, 28; 5-fluorouracil 600 mg/m2 days 1, 8, 29, 36; Adriamycin 30 mg/m2 days 1, 29; and mitomycin-C 10 mg/m2 day 1." | 7.67 | Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary. ( Falchuk, SC; Le Chevalier, T; Rouesse, J; Sevin, D; Spielman, M; Treat, J; Tremblay, C; Woolley, PV, 1989) |
| "KW 2083, which is a new mitomycin C derivative currently under clinical investigation, was tested for its antitumor effect on the growth of human carcinoma of the lung by using an in vitro clonogenic assay system." | 7.67 | Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay. ( Hoshi, A; Kanzawa, F; Matsushima, Y; Miyazawa, N; Saijo, N; Shimizu, E, 1985) |
| "Fifty-four patients with adenocarcinoma and large cell carcinoma of the lung, 16 with localized surgically resected disease and 38 with metastatic disease, were treated with 5-fluorouracil, doxorubicin, and mitomycin-C (FAM), in an attempt to prolong previously reported survival times in the patients." | 7.67 | 5-Fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung. ( Shaw, MK; Shaw, MT, 1987) |
| "Fourteen patients with advanced adenocarcinoma of the lung were treated with a combination chemotherapy of mitomycin C, adriamycin and cisplatin (MAP)." | 7.67 | [Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity]. ( Fujii, M; Kiura, K; Okabe, K; Toki, H, 1987) |
| "Fifty-three patients with inoperable adenocarcinoma of the lung were treated with 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) in two dose schedules: schedule 1--5-FU 600 mg/m2 days 1, 8, 29, and 36 and Adriamycin 30 mg/m2 days 1 and 29 and mitomycin-C 10 mg/m2 day 1 repeated every 8 weeks." | 7.67 | 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung. ( Burkes, R; DeBoer, G; Evans, WK; Paul, K; Shepherd, FA, 1986) |
| "Sixty-two patients with metastatic hormonal refractory adenocarcinoma of the prostate received a combination of doxorubicin, mitomycin-C, and 5-fluorouracil (DMF)." | 7.66 | Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. ( Grant, C; Johnson, DE; Logothetis, CJ; Ogden, S; Samuels, ML; Trindade, A; von Eschenbach, AC, 1983) |
| " The aim was to investigate the therapeutic efficacy and tolerance of mitomycin C (MMC) in combination with gemcitabine (GEM) or capecitabine (CAPE) in previously untreated patients with advanced biliary tract cancer." | 6.71 | Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. ( Depisch, D; Gruenberger, T; Karall, K; Kornek, GV; Laengle, F; Lang, F; Penz, M; Scheithauer, W; Schuell, B, 2004) |
| "Mitomycin was incriminated in both cases." | 5.31 | Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. ( Capron, F; Gagnadoux, F; Lebeau, B, 2002) |
| " There was a significant correlation between the area under the time versus concentration curve (AUC) of MMC and the age of patients (r = 0." | 5.28 | Pharmacokinetic study of mitomycin C with emphasis on the influence of aging. ( Karato, A; Miya, T; Saijo, N; Sasaki, Y, 1992) |
| "Patients with high-grade soft tissue sarcomas were treated with 2 cycles of ifosfamide, mitomycin, doxorubicin, and cisplatin plus GM-CSF subcutaneous followed by 45 Gy irradiation with concurrent 2 cycles of mitomycin, doxorubicin, and cisplatin followed by surgery +/- intraoperative radiation or brachytherapy." | 5.22 | Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively. ( Haddock, M; Mahoney, M; Maples, W; Markovic, SN; O'Connor, MI; Okuno, S; Petersen, I; Shives, T; Sim, F, 2016) |
| "We investigated the efficacy and safety of oral Uracil/tegafur (UFT) with leucovorin and mitomycin C (MMC) as third-line treatment for patients with extensively pretreated metastatic colorectal cancer (mCRC)." | 5.16 | Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study. ( Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D, 2012) |
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 5.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "The aim of this study was to evaluate the activity and toxicity of a combination regimen of CPT-11 and mitomycin-c as second-line chemotherapy for pretreated patients with advanced, metastatic, or both, gastric adenocarcinoma." | 5.11 | Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). ( Battaglia, C; Colucci, G; Di Bisceglie, M; Gebbia, N; Gebbia, V; Giuliani, F; Maiello, E; Molica, S; Vinciarelli, G, 2005) |
| "We conducted a multi-center study to investigate the usefulness of a combination drug therapy with doxifluridine (5'-DFUR) and mitomycin C (MMC) in colorectal cancer patients with lung metastasis." | 5.09 | [Combination chemotherapy of doxifluridine plus mitomycin C for colorectal lung metastasis--phase II study]. ( Fujita, H; Hiki, Y; Ike, H; Mitomi, T; Otani, Y; Oya, K; Sadahiro, S; Shimada, H; Yamaguchi, S, 2001) |
| "Between October 1986 and June 1997, 39 patients with advanced inoperable malignant mesothelioma were treated with palliative MVP (mitomycin-C 8 mg/m2 q." | 5.08 | Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma. ( Ashley, S; Hickish, T; Middleton, GW; Norton, A; O'Brien, ME; Priest, K; Smith, IE; Spencer, L, 1998) |
| "A prospective randomized study to compare the effectiveness of pleurodesis by two new sclerosing agents: OK-432 and mitomycin C were conducted in 53 patients with malignant pleural effusion caused by lung cancer." | 5.07 | Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. ( Chang, DB; Kuo, SH; Lee, LN; Luh, KT; Yang, PC; Yu, CJ, 1992) |
| "Fifty patients with inoperable adenocarcinoma of the lung were randomized in a prospective study to receive either standard doses or high doses of 5-fluorouracil, adriamycin, and mitomycin-C (FAM versus Hi-FAM)." | 5.06 | 5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules. ( Ip, M; Kung, TM; Lam, WK; Sham, MK; So, SY, 1987) |
| " Twenty-four patients with malignant pericardial effusion were treated by intrapericardial instillation of anti-cancer drugs, such as Carbazilquinone, Mitomycin-C or ACNU, with pericardial drainage." | 5.05 | [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion]. ( Fukuoka, M; Matsui, K; Negoro, S; Ryu, S; Sakaguchi, K; Sakai, N; Takada, M; Tamai, S, 1984) |
| "Between November 2002 and January 2015, 14 patients with 29 unresectable pulmonary or mediastinal breast cancer metastases underwent transcatheter arterial chemoembolization using SAP-MS (50-100 μm) after injection of a combination of 2-4 types of anticancer drugs (eg, cisplatin [30 mg] + fluorouracil [500 mg], or epirubicin [40 mg] + mitomycin C [4 mg] + fluorouracil [500 mg])." | 3.85 | Transcatheter Arterial Chemoembolization with Spherical Embolic Agent in Patients with Pulmonary or Mediastinal Metastases from Breast Cancer. ( Hori, A; Hori, S; Kennoki, N; Yuki, T, 2017) |
| " The tested 4g,h, 6a-h, 10 and 12-14 exhibited remarkable cytotoxicity activity against breast cancer cell line MCF-7 with higher activity than tamoxifen." | 3.78 | Synthesis and docking studies of novel antitumor benzimidazoles. ( Ali, MM; El Diwani, HI; Galal, SA; Kerwin, SM; Li, J; Omar, MA; Ramadan, RA; Shaker, YM; Tokuda, H, 2012) |
| "To evaluate the clinical efficacy and safety of mitomycin C in the local control of malignant pericardial effusion, we carried out a trial of pericardial drainage with local instillation of mitomycin C in eight patients who suffered from cardiac tamponade or symptomatic large pericardial effusion caused by advanced non-small cell lung cancer." | 3.73 | Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer. ( Horie, T; Imai, H; Inazawa, M; Kaira, K; Kobayashi, G; Mori, M; Mori, T; Takise, A; Utsugi, M, 2005) |
| "Fanconi anemia (FA) results from mutations in a group of genes whose products, including BRCA2 and BACH1/BRIP1, are known to function in one common pathway (the FA-BRCA pathway) to guard genome integrity, especially when challenged by DNA crosslinking agents, such as Cisplatin and mitomycin C (MMC)." | 3.73 | Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells. ( Couch, FJ; Fei, P; Lin, CJ; Wang, X; Zhang, J, 2006) |
| " Nitrotriazole chemosensitizer in ultralow doses increased the sensitivity of leukemia P388/rn substrain with multiple drug resistance phenotype to mitomycin C during combination therapy." | 3.72 | Ultralow doses of various drugs in chemotherapy of experimental tumors. ( Konovalova, NP, 2003) |
| "A patient with mitomycin-associated hemolytic-uremic syndrome received SPA treatments after her ACE inhibitor, lisinopril, was held." | 3.71 | Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation. ( Adam, A; Eastlund, T; Hammerschmidt, D; Koenigbauer, U; Lepage, Y; Molinaro, G, 2002) |
| "Twenty patients with malignant pericardial effusion were treated by ultrasound guided pericardiocentesis and the intrapericardial instillation of mitomycin C." | 3.69 | Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion. ( Chang, DB; Ko, JC; Lee, LN; Liaw, YS; Luh, KT; Wu, RG; Yang, PC; Yu, CJ, 1994) |
| "Two cases of recurrent breast cancer, for which combined therapy using toremifene and oral chemotherapeutic agents were effective, are reported." | 3.69 | [Complete tumor regression obtained by chemoendocrine therapy including toremifene in two cases of pulmonary metastasis of breast cancer with a history of tamoxifen treatment]. ( Asanuma, F; Miyagawa, T; Toyoda, H; Uesato, K; Yamada, Y, 1997) |
| "We developed a mitomycin C (MMC)-resistant human lung adenocarcinoma cell subline, SPC-A1/DM4, from cloned SPC-A1/D13 parent cells by 1 h exposures to escalating concentrations of the drug over 17 months." | 3.68 | Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance. ( Dong, QG; Gong, LL; Wang, EZ; Wang, HJ, 1993) |
| "To evaluate the efficacy of a combined therapy of prednisolone and alprazolam for controlling cisplatin-induced delayed emesis, a study involving 14 non-small cell lung cancer patients receiving cisplatin (80 mg/m2) was conducted." | 3.68 | [A combined anti-emesis therapy of oral prednisolone and alprazolam for cisplatin-induced delayed emesis]. ( Horio, Y; Iwahara, T; Minami, H; Sakai, S; Shibagaki, T; Shimokata, K; Watanabe, A, 1990) |
| "Twenty-six patients with advanced bronchogenic adenocarcinoma or large cell carcinoma were treated by combination chemotherapy consisting of Ftorafur, adriamycin and mitomycin C (FAM II)." | 3.67 | Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma. ( Cruciani, AR; De Marinis, A; Nunziati, F; Portalone, L; Salvati, F, 1984) |
| "The disposition kinetics of the cancer chemotherapeutic agent mitomycin C have been studied in six male patients receiving mitomycin C in combination with cisplatin and vinblastine for non-oat cell carcinoma of the lung." | 3.67 | Pharmacokinetics of mitomycin C in non-oat cell carcinoma of the lung. ( Buice, RG; Gurley, BJ; Niell, HB; Sidhu, P, 1984) |
| "Fourteen cases of adenocarcinoma with pleuritis carcinomatosa (lung cancer 10 cases, ovarian cancer 2 cases, colon cancer 2 cases) were treated with intra-pleural instillation of 7-N-(p-hydroxyphenyl)-mitomycin C (KW-2083), a derivative of mitomycin C." | 3.67 | [Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa]. ( Eguchi, K; Garcia-Herreros, P; Hoshi, A; Nomori, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Tominaga, K, 1984) |
| " The nausea and vomiting were reasonably well controlled with methylprednisolone and metoclopramide." | 3.67 | [Clinical study of chemotherapy (PPM therapy) with cisplatin, peplomycin and mitomycin C in squamous cell lung cancer]. ( Arai, S; Honda, Y; Ito, T; Kato, M; Kawata, Y; Kori, Y; Koyama, M, 1986) |
| " Treatment regimens usually employed cis-diammine-dichloroplatinum (CDDP) plus peplomycin for squamous cell carcinoma, and CDDP plus vindesine for adenocarcinoma." | 3.67 | [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion]. ( Inoue, F; Mimura, H; Miyake, M; Mori, T; Orita, K; Takeda, I; Tanaka, N, 1988) |
| "Nineteen patients with adenocarcinoma of unknown primary were treated with the m-FAM regimen, consisting of methotrexate 50 mg/m2 days 0, 28; 5-fluorouracil 600 mg/m2 days 1, 8, 29, 36; Adriamycin 30 mg/m2 days 1, 29; and mitomycin-C 10 mg/m2 day 1." | 3.67 | Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary. ( Falchuk, SC; Le Chevalier, T; Rouesse, J; Sevin, D; Spielman, M; Treat, J; Tremblay, C; Woolley, PV, 1989) |
| "KW 2083, which is a new mitomycin C derivative currently under clinical investigation, was tested for its antitumor effect on the growth of human carcinoma of the lung by using an in vitro clonogenic assay system." | 3.67 | Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay. ( Hoshi, A; Kanzawa, F; Matsushima, Y; Miyazawa, N; Saijo, N; Shimizu, E, 1985) |
| "Fifty-four patients with adenocarcinoma and large cell carcinoma of the lung, 16 with localized surgically resected disease and 38 with metastatic disease, were treated with 5-fluorouracil, doxorubicin, and mitomycin-C (FAM), in an attempt to prolong previously reported survival times in the patients." | 3.67 | 5-Fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung. ( Shaw, MK; Shaw, MT, 1987) |
| "Fourteen patients with advanced adenocarcinoma of the lung were treated with a combination chemotherapy of mitomycin C, adriamycin and cisplatin (MAP)." | 3.67 | [Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity]. ( Fujii, M; Kiura, K; Okabe, K; Toki, H, 1987) |
| "Fifty-three patients with inoperable adenocarcinoma of the lung were treated with 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) in two dose schedules: schedule 1--5-FU 600 mg/m2 days 1, 8, 29, and 36 and Adriamycin 30 mg/m2 days 1 and 29 and mitomycin-C 10 mg/m2 day 1 repeated every 8 weeks." | 3.67 | 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung. ( Burkes, R; DeBoer, G; Evans, WK; Paul, K; Shepherd, FA, 1986) |
| "Sixty-two patients with metastatic hormonal refractory adenocarcinoma of the prostate received a combination of doxorubicin, mitomycin-C, and 5-fluorouracil (DMF)." | 3.66 | Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. ( Grant, C; Johnson, DE; Logothetis, CJ; Ogden, S; Samuels, ML; Trindade, A; von Eschenbach, AC, 1983) |
| " Results of treatment of B16 melanoma and Lewis lung carcinoma with 3,4-dihydroxybenzohydroxamic acid are used to demonstrate this definition." | 3.66 | Drug activity and therapeutic synergism in cancer treatment. ( Campbell, ED; Carter, WH; Stablein, DM; Wampler, GL, 1982) |
| "Secondary objectives were time to disease progression, response rates, evaluation of toxicity, disease-related symptoms, World Health Organization performance status (PS), and quality of life (QoL)." | 2.71 | Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. ( Anderson, H; Ashcroft, L; Beresford, C; Burt, PA; Clemons, M; Danson, S; Dowd, I; Fairve-Finn, C; Hassan, J; Middleton, MR; O'Byrne, KJ; Ranson, M; Stout, R; Thatcher, N, 2003) |
| " Haematological toxicity and dosage reductions were higher with SuperMIP, which was nevertheless associated with a significantly increased absolute dose intensity." | 2.71 | A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer. ( Berghmans, T; Corhay, JL; Efremidis, A; Giner, V; Koumakis, G; Lafitte, JJ; Lecomte, J; Lothaire, P; Mommen, P; Ninane, V; Paesmans, M; Richez, M; Sculier, JP; Thiriaux, J; Van Houtte, P; Wackenier, P, 2004) |
| " The aim was to investigate the therapeutic efficacy and tolerance of mitomycin C (MMC) in combination with gemcitabine (GEM) or capecitabine (CAPE) in previously untreated patients with advanced biliary tract cancer." | 2.71 | Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. ( Depisch, D; Gruenberger, T; Karall, K; Kornek, GV; Laengle, F; Lang, F; Penz, M; Scheithauer, W; Schuell, B, 2004) |
| "Mitomycin-C was later dropped from the induction regimen." | 2.70 | Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology G ( Byhardt, RW; Ettinger, D; Johnstone, DW; Scott, CB, 2002) |
| "To observe the effects of chemotherapy combined with Chinese herbal medicine (Spleen-Kidney tonifying) in treating advanced tumor patients and on immune parameters." | 2.70 | [Clinical observation on effect of chemotherapy combined with Chinese medicine in treating advanced tumor patients and on immunologic parameters]. ( Gong, LY; Jiang, CM; Pang, MR, 2001) |
| "This communication represents the definitive report of a randomized phase III study comparing cisplatin and carboplatin, in combination with vindesine and mitomycin C in stage IIIB and IV squamous-cell bronchogenic carcinoma." | 2.70 | Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study. ( Babović, N; Elezar, E; Gavrilović, D; Jelić, S; Kovacević, S; Kovcin, V; Mitrović, L; Radosavljević, D; Radulović, S; Tomasević, Z, 2001) |
| " 28 evaluable patients with previously untreated symptomatic NSCLC and mesothelioma were randomized to receive either 3 weekly intravenous combination chemotherapy alone, or chemotherapy given with monthly intra-dermal injections of SRL172." | 2.69 | A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma. ( Bromelow, KV; Gregory, K; Kennard, DA; Mendes, R; O'Brien, ME; Palmer, RD; Priest, K; Ryan, C; Saini, A; Smith, IE; Souberbielle, BE; Tuckwell, N; Webb, A, 2000) |
| " Our trial failed to demonstrate a significant improvement in response or survival when patients with metastatic NSCLC were treated, in addition to ifosfamide and mitomycin, by combination of moderate dosages of cisplatin and carboplatin instead of moderate dosage of cisplatin alone." | 2.69 | Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer. ( Alexopoulos, CG; Baumöhl, J; Berghmans, T; Florin, MC; Klastersky, J; Koumakis, G; Lafitte, JJ; Mommen, P; Ninane, V; Paesmans, M; Schmerber, J; Sculier, JP; Thiriaux, J; Zacharias, C, 2000) |
| " No toxic death occurred." | 2.68 | Symptomatic, stage IV, non-small-cell lung cancer (NSCLC): response, toxicity, performance status change and symptom relief in patients treated with cisplatin, vinblastine and mitomycin-C. ( Cellerino, R; Graziano, F; Isidori, P; Tummarello, D, 1995) |
| " The aim of this phase I study was to determine the toxicity profile and the optimal dosage of KW-2149." | 2.68 | Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149. ( Ardiet, C; Catimel, G; De Bruijn, E; Dirix, L; Dumortier, A; Evene, E; Joossens, E; Koier, I; Provè, A; Schrijvers, D, 1995) |
| "12." | 2.68 | Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer. ( Kimura, H; Yamaguchi, Y, 1995) |
| "Treatment with mitomycin C and menadione was well tolerated except for hematologic toxicity and cardiac events of unclear relationship to the study drugs." | 2.68 | Mitomycin C and menadione for the treatment of lung cancer: a phase II trial. ( Ahn, C; Akman, S; Chow, W; Doroshow, JH; Leong, L; Margolin, K; Morgan, RJ; Raschko, J; Somlo, G; Tetef, M, 1995) |
| " Chemotherapy consisted of three dosage regimens: (1) vindesine and cisplatin (VP); (2) mitomycin, vindesine and cisplatin (MVP); or (3) etoposide and cisplatin alternating with vindesine and mitomycin (EP/VM)." | 2.68 | Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer. ( Fukuoka, M; Furuse, K; Kawahara, M; Kodama, N; Kubota, K; Kudoh, S; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ogawara, M; Takada, M; Takifuji, N, 1997) |
| "61 cases of the gastric cancers have been treated with Replenishing Qi and Invigorating Spleen (RQIS) combined with chemotherapy." | 2.67 | [Clinical and experimental study in treating gastric cancer with replenishing qi and invigorating spleen oral liquid combined with chemotherapy]. ( Chen, CH; Sun, GZ; Wang, GM, 1994) |
| " QDBS syndrome is somehow related to immuno-deficiency and blood hypercoagulability, the method of Yiqi Huoxue (YQHX) which used to be combined with chemotherapy could not only reduce the toxic-side effects of chemotherapy, but also improve the cellular immune function and hemorheology." | 2.67 | [Studies of guben quyu No I combined with chemotherapy in treating cancer]. ( Peng, XM; Rao, XQ; Yu, RC, 1994) |
| "Mitomycin C has antitumor activity against squamous cell lung carcinoma when used alone or in combination with MVP." | 2.67 | A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma. ( Dalton, RJ; Etzell, PS; Foley, JF; Jett, JR; Kardinal, CG; Mailliard, JA; Maksymiuk, AW; Marschke, RF; Su, JQ; Veeder, MH, 1992) |
| "A total of 49 patients with metastatic renal cell cancer underwent recombinant interferon-alpha 2a therapy combined with chemotherapy." | 2.67 | Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer. ( Amato, R; Dexeus, FH; Fitz, K; Kilbourn, R; Logothetis, CJ; Sella, A; Wallace, S, 1992) |
| "Although histology (squamous vs." | 2.67 | Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival. ( Aso, H; Hara, N; Ichinose, Y; Kuda, T; Motohiro, A; Ohta, M, 1991) |
| "Twenty-seven pts with squamous cell carcinoma were randomized between regimen PMP (CDDP 60 mg/m2, d 1, MMC 6 mg/m2, d 3, d 10 and PEP 5 mg/m2, d 3-7) and regimen PM (CDDP 60 mg/m2, d 1 and MMC 6 mg/m2, d 3, d 10)." | 2.66 | [A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer]. ( Abe, S; Miyamoto, H; Nakabayashi, T; Ohosaki, Y; Yasuda, S, 1986) |
| " During the past eleven years, we have used postoperative chemotherapy in three ways over three different periods: in the earliest period, short-term combined chemotherapy (STCC) was used, in the middle period, intermittent long-term combined chemotherapy (ILTCC) was used in combination with immunotherapy for a randomized group, and in the latest period, when continuous long-term combined chemotherapy (CLTCC) with immunotherapy was employed." | 2.66 | [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy]. ( Hashizume, Y; Ichihashi, T; Iida, S; Kimoto, H; Kobayashi, H; Sato, H; Shimizu, J; Tsunamura, Y; Watanabe, Y; Yamada, T, 1985) |
| "The effect of fibrinolytic agents, Tissue Culture Urokinase (TCUK) and Urinary Urokinase (UUK), was investigated in a total of 146 patients with gastric cancer, pulmonary cancer or breast cancer who received various anti-cancer agents, mainly MMC, in combination with the fibrinolytic agents." | 2.65 | [Clinical evaluation of various antineoplastic agents combined with urokinase--a comparison between urokinase from tissue culture (TCUK) and urine-derived urokinase (UUK)]. ( Yamamoto, M, 1982) |
| "Secondary spontaneous pneumothorax (SSP) is a rare complication of chemotherapy for pulmonary metastases and to the best of our knowledge, only 28 cases have been described, most of which occurred in patients with osteosarcoma or germ cell tumors." | 2.41 | Bilateral recurrent pneumothorax complicating chemotherapy for pulmonary metastatic breast ductal carcinoma: report of a case. ( Ansaloni, L; Bazzocchi, R; Bini, A; Grazia, M; Stella, F; Zompatori, M, 2000) |
| "Mitomycin has proven to be among the most active drugs available for the single-agent treatment of non-small cell lung cancer (NSCLC)." | 2.38 | Experience with mitomycin in the treatment of non-small cell lung cancer. ( Folman, RS, 1993) |
| "This is even lower in triple-negative breast cancer (TNBC) patients with concomitant lung metastases." | 1.51 | Isolated thoracic perfusion in lung metastases from breast cancer: a retrospective observational study. ( Aigner, K; Clementi, M; Deraco, M; Fiorentini, G; Guadagni, S; Masedu, F; Ricevuto, E; Zoras, O, 2019) |
| "Stage IV squamous cell carcinoma of the anus outcomes are poor, but first-line chemotherapy can enable good response rates." | 1.46 | Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience. ( Benezery, K; Cavaglione, G; Doyen, J; Evesque, L; Follana, P; François, E; Reure, J; Tuan Falk, A, 2017) |
| " Adverse effects on the gastrointestinal tract also were lower than in controls (p<0." | 1.40 | Safety of Brucea javanica and cantharidin combined with chemotherapy for treatment of NSCLC patients. ( Huang, XE; Ji, ZQ; Liu, J; Tang, JH; Wang, L; Wu, XY, 2014) |
| "Patients with PC from colorectal or appendiceal cancer, pseudomyxoma peritonei or malignant peritoneal mesothelioma referred to the single national HIPEC centre were prospectively registered from June 2006 to July 2012." | 1.39 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience. ( Hagemann-Madsen, R; Iversen, LH; Laurberg, S; Rasmussen, PC, 2013) |
| "Median time to disease progression was 4 months, and median survival was 9+ months." | 1.39 | Is there still a role for mitomycin-based combination chemotherapy in treating patients with nonsmall cell lung cancer? A single institution experience. ( Antonelli, G; Blandino, R; Calì, S; Ferraù, F; Malaponte, E; Panebianco, V; Vitale, FV, 2013) |
| "It includes 51 cases of squamous cell carcinoma, 6 cases of adenocarcinoma and 1 case of adenosquamous carcinoma." | 1.37 | [Evaluation of the efficacy of bronchial arterial infusion chemotherapy for the treatment of central non-small cell lung cancer]. ( Chen, Y; Li, H; Liu, DZ; Yan, D; Zeng, HY; Zhou, CW, 2011) |
| "In emodin- and MMC-cotreated cells, ERK1/2 phosphorylation was enhanced by constitutively active MKK1/2 (MKK1/2-CA), thus increasing Rad51 protein levels and protein stability." | 1.36 | Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small-cell lung cancer cells. ( Cheng, CM; Chiu, YF; Kuo, YH; Lin, ST; Lin, YW; Su, YJ; Tsai, MS, 2010) |
| "A case of hepatocellular carcinoma, successfully treated with multimodal loco-regional treatments, is reported." | 1.36 | [Successful treatment of multiple pulmonary and peritoneal recurrence of hepatocellular carcinoma with bronchial artery infusion therapy and PEIT followed by surgery--a case report]. ( Akiyama, H; Amikura, K; Kawashima, Y; Nakajima, T; Nishimura, Y; Sakamoto, H; Tanaka, Y; Yamagata, Y; Yamaura, T; Yatsuoka, T; Yokoyama, Y, 2010) |
| "Generalized metastases showed substantial progression." | 1.32 | Lung carcinoma with congenital plantar keratoderma as a variant of Clarke-Howel-Evans syndrome. ( Bonnekoh, B; Franke, I; Gollnick, H; Grundmann, JU; Weisshaar, E, 2003) |
| "Hemoptysis was negligible until he died 8 months later." | 1.32 | [Clinical benefit of bronchial arterial infusion chemotherapy to pulmonary metastasis from colorectal cancer--report of two cases]. ( Ishigaki, T; Kitai, T; Kojima, N; Miki, A; Nishikawa, S; Nomura, A; Todo, G; Ukikusa, M, 2003) |
| "Bioluminescent PC-3M-luc-C6 human prostate cancer cells were implanted subcutaneously into SCID-beige mice and were monitored for tumor growth and response to 5-FU and mitomycin C treatments." | 1.32 | Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. ( Contag, PR; Dusich, J; Hornig, YS; Jenkins, DE; Oei, Y; Purchio, T; Yu, SF, 2003) |
| "Multiple endobronchial squamous cell carcinoma is sometimes difficult to resect due to poor pulmonary function." | 1.31 | Induction chemotherapy before operation for multiple endobronchial squamous cell carcinoma of the lung. ( Hayashi, E; Huang, CL; Kameyama, K; Liu, D; Okamoto, T; Yamamoto, Y; Yokomise, H, 2002) |
| "Mitomycin was incriminated in both cases." | 1.31 | Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. ( Capron, F; Gagnadoux, F; Lebeau, B, 2002) |
| "Irofulven has demonstrated activity against a broad range of solid tumors in both xenograft models and human trials." | 1.31 | Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C. ( Estes, L; Kelner, MJ; McMorris, TC; Rojas, RJ; Trani, NA, 2002) |
| "Three patients with colorectal cancer and pulmonary metastasis who had previously undergone surgical treatment, were treated by combination chemotherapy with CDDP and 5-FU regimen, but the growth of the metastatic tumor could not be controlled finally." | 1.30 | [Three cases of colorectal cancer with lung metastasis successfully treated with combination chemotherapy using 5'-DFUR and MMC]. ( Horie, H; Hosoya, Y; Ishizuka, T; Kanazawa, K; Kashiwagi, H; Kojima, M; Konishi, H; Shitou, K, 1998) |
| " CGP 69846A, in combination with cisplatin, showed superadditive antitumor effects against PC3 human prostate carcinomas with tumor cures, and in combination with mitomycin C, superadditive antitumor effects of CGP 69846A with tumor cures against NCI-H460 large cell lung carcinoma were found." | 1.30 | Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice. ( Fabbro, D; Geiger, T; Monia, BP; Müller, M, 1997) |
| " To explain this tumor selectivity, the distribution of FK317 was investigated after dosing tumor-bearing mice with the 14C-labelled compound." | 1.30 | FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice. ( Fujiwara, T; Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Naoe, Y; Nishigaki, F; Shimomura, K; Takagaki, S; Tsujimoto, S; Yamazaki, S, 1998) |
| "We report a 68-year-old man with rectal cancer and recurrent pulmonary metastasis treated with concomitant 5'-DFUR + MMC, which resulted in an extreme reduction of the lesion." | 1.30 | [Combination of 5'-DFUR and MMC for recurrent rectal cancer with pulmonary metastasis]. ( Aihara, S; Hiki, Y; Ishikawa, H; Kakita, A; Kanazawa, H; Ohtani, Y, 1999) |
| "5 mg/kg), or cisplatin (4 mg/kg, by one shot) to TNP (120-140 mg/kg) with a 6-7 fractionated dosing schedule reduced s." | 1.29 | Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice. ( Kakinuma, H; Kato, T; Matsuda, Y; Sato, K, 1994) |
| " There was significant correlation between the age of the patients and U-Pt pharmacokinetic parameters such as the area under the plasma concentration versus time curve (AUC), total clearance (Cl), and peak plasma concentration (Cmax) as well as the AUC of T-Pt (P < 0." | 1.29 | The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function. ( Ando, M; Eguchi, K; Katsumata, N; Maeda, M; Ohe, Y; Oshita, F; Shinkai, T; Shiraishi, J; Tamura, T; Yamamoto, N, 1995) |
| "We have investigated the therapeutic effect of CH-271 fusion polypeptide containing both cell-binding domain (C-274) and heparin-binding domain (H-271) of fibronectin in combination with anticancer drugs such as doxorubicin (DOX) or mitomycin C (MMC) on tumor metastasis of different types of tumors." | 1.29 | Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs. ( Azuma, I; Igarashi, Y; Ishizaki, Y; Kato, I; Kobayashi, H; Komazawa, H; Saiki, I; Yoneda, J, 1993) |
| "Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung." | 1.28 | Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis. ( Eagan, RT; Feldman, ER; Schaid, DJ, 1992) |
| " There was a significant correlation between the area under the time versus concentration curve (AUC) of MMC and the age of patients (r = 0." | 1.28 | Pharmacokinetic study of mitomycin C with emphasis on the influence of aging. ( Karato, A; Miya, T; Saijo, N; Sasaki, Y, 1992) |
| "Mitomycin C was injected intermittently in the hepatic artery more than 10 times." | 1.28 | [Intra-arterial infusion chemotherapy using implantable reservoir for liver metastasis of the lung cancer--an effective case]. ( Ishihara, T; Kawamura, M; Kikuchi, K; Kobayashi, T; Mouri, M; Watanabe, M, 1992) |
| "SPG also inhibited the pulmonary metastasis of NR-S1 tumor after radiotherapy." | 1.28 | Combination therapy of radiation and Sizofiran (SPG) on the tumor growth and metastasis on squamous-cell carcinoma NR-S1 in syngeneic C3H/He mice. ( Amemiya, K; Arika, T; Nomoto, K, 1992) |
| "A woman born in 1924 with colon cancer initially operated on approximately four years ago showed a second recurrence in the lung." | 1.28 | [A case of pulmonary metastasis from colon cancer responding completely to high-dose 5'-DFUR plus MMC combination chemotherapy]. ( Kawahara, T; Kikkawa, N; Kobayakawa, K; Tsuchiya, Y; Tsumura, I, 1991) |
| "The effect on squamous cell carcinoma was more prominent than on other cell types." | 1.28 | Reappraisal of bronchial arterial infusion therapy for advanced lung cancer. ( Iwa, T; Kitagawa, M; Matsubara, F; Mizukami, Y; Murakami, S; Nonomura, A; Shimizu, J; Tsubota, M; Watanabe, Y; Yoshida, M, 1990) |
| "Of the 15 patients who developed brain metastases after prior chemotherapy, 12 had received MAC at least once prior to the diagnosis of brain metastases, and in 5 patients, MAC was the first chemotherapy given after the diagnosis of brain metastases." | 1.28 | Intracerebral choriocarcinoma. ( Jones, WB; Lewis, JL; Wagner-Reiss, KM, 1990) |
| "Histologically, 16 had squamous cell carcinoma, 11 adenocarcinoma, 3 small cell anaplastic carcinoma and 1 un-classified cancer." | 1.28 | [Bronchial arterial infusion chemotherapy with or without radiotherapy for advanced lung cancer]. ( Huang, DP, 1990) |
| "Lymphocytes from 21 male smokers, 10 untreated lung cancer patients, and 11 controls were cultured with and without exposure to mitomycin C." | 1.28 | No difference between smoking lung cancer patients and smoking controls in the frequency of spontaneous and mitomycin C induced chromosome aberrations in lymphocytes. ( Johansson, M; Orndal, C, 1989) |
| "A 68-year-old male, who had advanced rectal cancer with multiple pulmonary metastases, had undergone resection of rectal cancer operatively and was treated with a combination chemotherapy using 5'-DFUR (5'-deoxy-5-fluorouridine) and MMC (mitomycin C) for multiple pulmonary metastases." | 1.28 | [A case of multiple pulmonary metastases from rectal cancer which responded completely to combination chemotherapy using 5'-DFUR and MMC]. ( Baba, K; Kawano, H; Matsuda, M; Matsuoka, Y; Morinaga, H; Nagao, K; Nagase, H; Nishimura, R; Ueno, Y, 1989) |
| "Mitomycin-C was evaluated in a disease-oriented phase II trial in patients with small cell lung cancer who had failed prior conventional chemotherapy." | 1.27 | Phase II trial of mitomycin-C in patients with small cell carcinoma of the lung after failure on combination chemotherapy. ( Alberto, P; Cavalli, F; Joss, RA; Obrecht, JP; Sauter, C; Senn, HJ, 1984) |
| " At this time the ITC therapy is used in combination with induced-hypertension-chemotherapy (IHC therapy)." | 1.27 | [The clinical effect of hyperthermia combined with induced hypertension chemotherapy]. ( Hayashida, S; Kobayashi, T; Sugimoto, K, 1984) |
| "Lymphocytes from patients with squamous cell carcinoma, large cell carcinoma and carcinoid exhibited positive activity levels of 11." | 1.27 | Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor. ( Fujisawa, T; Kadoyama, C; Kimura, H; Sato, N; Yamaguchi, Y, 1983) |
| "The effect of multidisciplinary treatment of small cell carcinoma of the lung was tested." | 1.27 | [Multidisciplinary treatment for small cell lung cancer]. ( Eguchi, K; Saijo, N; Sasaki, Y; Seki, S; Shimizu, E; Shinkai, T; Takahashi, K; Tominaga, K, 1984) |
| "Metronidazole, 1." | 1.27 | Feasibility study of combining metronidazole with chemotherapy. ( Bélanger, R; Crook, AF; Heringer, R; Hopkins, HS; Hugenholtz, H; Maroun, JA; Richard, MT; Stewart, DJ; Yan, RC; Young, V, 1983) |
| "Intracarotid CDDP infusion in combination with angiotensin II was performed in two patients with metastatic brain tumor, lung carcinoma (LC) and ovarian carcinoma (OC)." | 1.27 | [Intracarotid arterial infusion with CDDP in combination with angiotensin II]. ( Hino, N; Mitsuhata, N; Nishigaki, S; Suga, K; Tagusagawa, Y, 1984) |
| "The PR cases were 4 of stomach cancer and 2 of lung cancer, the former being all undifferentiated adenocarcinoma." | 1.27 | [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers]. ( Harashima, S; Kanko, T; Nakao, I; Nishi, I; Ohashi, Y; Saito, T; Yokoyama, T, 1984) |
| "Namely, most solid tumors possess four different unique features: hypervasculature, enhanced permeability even to macromolecules, architectural differences, and lack of the lymphatic recovery system." | 1.27 | [Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome]. ( Konno, T; Maeda, H, 1985) |
| "The most frequent histology was squamous cell carcinoma found in 20 patients." | 1.27 | [Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma]. ( Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R, 1985) |
| "The disease appeared to be a diffuse encephalopathy frequently affecting the higher cortical functions." | 1.27 | Neurologic dysfunction in patients treated for small cell carcinoma of the lung: a clinical and radiological study. ( Chak, LY; Cox, RS; Kushlan, PD; Porzig, KJ; Sikic, BI; Wasserstein, P; Zatz, LM, 1986) |
| "The mitomycin C and BCNU were alternated monthly at the start of each FUDR cycle." | 1.27 | Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy. ( Cohen, AM; Higgins, J; Schaeffer, N, 1986) |
| " A dual-phase attenuation curve was obtained after the completion of infusion and the half-life period of the beta-phase was around 200 hours." | 1.27 | [The pharmacokinetics of cisplatin and its influence on renal functions based on different infusion methods]. ( Amano, H; Hishida, H; Ogura, Y; Saji, E; Takagi, M; Takagi, N; Takahashi, A, 1987) |
| "Alveolar soft part sarcoma is a rare soft tissue tumor arising in extremities." | 1.27 | [Pulmonary manifestations of alveolar soft part sarcoma; bronchial arterial embolization for hemoptysis]. ( Kikuchi, K; Masuda, H; Ogata, T; Takagi, K; Tanaka, S, 1988) |
| "After treatment, the incidence of lung metastasis was analyzed in LLC-inoculated mice, and the presence or absence of metastasis in affiliated lymph nodes was determined in mouse ascites hepatoma 134-inoculated mice." | 1.27 | Effects of total-body hyperthermia on metastases from experimental mouse tumors. ( Koga, S; Maeta, M; Oda, M, 1985) |
| " This three-drug combination appears to be an active regimen in the treatment of non-small-cell bronchogenic carcinoma; however, altered dosage schedules should be examined in order to decrease drug-related toxicity." | 1.27 | Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer. ( Griffin, JP; Niell, HB, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 168 (31.70) | 18.7374 |
| 1990's | 184 (34.72) | 18.2507 |
| 2000's | 129 (24.34) | 29.6817 |
| 2010's | 44 (8.30) | 24.3611 |
| 2020's | 5 (0.94) | 2.80 |
| Authors | Studies |
|---|---|
| Iwasa, K | 2 |
| Moriyasu, M | 1 |
| Yamori, T | 1 |
| Turuo, T | 1 |
| Lee, DU | 1 |
| Wiegrebe, W | 1 |
| McKee, ML | 1 |
| Kerwin, SM | 2 |
| Omar, MA | 1 |
| Shaker, YM | 1 |
| Galal, SA | 1 |
| Ali, MM | 1 |
| Li, J | 3 |
| Tokuda, H | 1 |
| Ramadan, RA | 1 |
| El Diwani, HI | 1 |
| Boas, FE | 1 |
| Kemeny, NE | 1 |
| Sofocleous, CT | 1 |
| Yeh, R | 1 |
| Thompson, VR | 1 |
| Hsu, M | 1 |
| Moskowitz, CS | 1 |
| Ziv, E | 1 |
| Yarmohammadi, H | 1 |
| Bendet, A | 1 |
| Solomon, SB | 1 |
| Hori, A | 2 |
| Ohira, R | 1 |
| Nakamura, T | 3 |
| Kimura, Y | 1 |
| Ueda, S | 1 |
| Torii, M | 1 |
| Kennoki, N | 2 |
| Hori, S | 2 |
| Luo, M | 1 |
| Wang, F | 1 |
| Zhang, H | 2 |
| To, KKW | 1 |
| Wu, S | 1 |
| Chen, Z | 1 |
| Liang, S | 1 |
| Fu, L | 1 |
| Ciniero, G | 1 |
| Elmenoufy, AH | 1 |
| Gentile, F | 1 |
| Weinfeld, M | 1 |
| Deriu, MA | 1 |
| West, FG | 1 |
| Tuszynski, JA | 1 |
| Dumontet, C | 2 |
| Cros-Perrial, E | 2 |
| Jordheim, LP | 2 |
| Raza, MZ | 1 |
| Cadassou, O | 1 |
| Evesque, L | 2 |
| Benezery, K | 1 |
| Follana, P | 2 |
| Tuan Falk, A | 1 |
| Doyen, J | 1 |
| Reure, J | 1 |
| Cavaglione, G | 1 |
| François, E | 2 |
| Yuki, T | 1 |
| Zhang, RX | 1 |
| Zhang, T | 2 |
| Amini, MA | 1 |
| He, C | 2 |
| Lu, B | 1 |
| Ahmed, T | 1 |
| Lip, H | 1 |
| Rauth, AM | 2 |
| Wu, XY | 3 |
| Malgras, B | 1 |
| Gayat, E | 1 |
| Aoun, O | 1 |
| Lo Dico, R | 1 |
| Eveno, C | 1 |
| Pautrat, K | 1 |
| Delhorme, JB | 1 |
| Passot, G | 1 |
| Marchal, F | 1 |
| Sgarbura, O | 1 |
| Ferron, G | 1 |
| Goéré, D | 1 |
| Andre, T | 1 |
| Pocard, M | 1 |
| Guadagni, S | 3 |
| Aigner, K | 1 |
| Zoras, O | 1 |
| Masedu, F | 1 |
| Fiorentini, G | 1 |
| Ricevuto, E | 2 |
| Deraco, M | 1 |
| Clementi, M | 1 |
| Iversen, LH | 1 |
| Rasmussen, PC | 1 |
| Hagemann-Madsen, R | 1 |
| Laurberg, S | 1 |
| Wibmer, T | 2 |
| Berghmans, T | 9 |
| Kropf-Sanchen, C | 1 |
| Lafitte, JJ | 8 |
| Rüdiger, S | 1 |
| Paesmans, M | 6 |
| Blanta, I | 1 |
| Scherpereel, A | 3 |
| Stoiber, KM | 1 |
| Rottbauer, W | 1 |
| Sculier, JP | 12 |
| Schumann, C | 2 |
| Friboulet, L | 1 |
| Postel-Vinay, S | 1 |
| Sourisseau, T | 1 |
| Adam, J | 1 |
| Stoclin, A | 1 |
| Ponsonnailles, F | 1 |
| Dorvault, N | 1 |
| Commo, F | 1 |
| Saulnier, P | 1 |
| Salome-Desmoulez, S | 1 |
| Pottier, G | 1 |
| André, F | 1 |
| Kroemer, G | 1 |
| Soria, JC | 2 |
| Olaussen, KA | 2 |
| Ozdemir, O | 1 |
| Ozdemir, P | 1 |
| Veral, A | 1 |
| Uluer, H | 1 |
| Ozhan, MH | 1 |
| Magge, D | 1 |
| Zenati, MS | 1 |
| Austin, F | 1 |
| Mavanur, A | 1 |
| Sathaiah, M | 1 |
| Ramalingam, L | 1 |
| Jones, H | 1 |
| Zureikat, AH | 1 |
| Holtzman, M | 1 |
| Ahrendt, S | 1 |
| Pingpank, J | 1 |
| Zeh, HJ | 1 |
| Bartlett, DL | 1 |
| Choudry, HA | 1 |
| Okuno, S | 1 |
| Petersen, I | 1 |
| Shives, T | 1 |
| Mahoney, M | 1 |
| Haddock, M | 1 |
| Sim, F | 1 |
| O'Connor, MI | 1 |
| Markovic, SN | 1 |
| Maples, W | 1 |
| Kim, K | 1 |
| Chie, EK | 1 |
| Jang, JY | 1 |
| Kim, SW | 1 |
| Han, SW | 1 |
| Oh, DY | 1 |
| Im, SA | 1 |
| Kim, TY | 1 |
| Bang, YJ | 1 |
| Ha, SW | 1 |
| Shetty, SJ | 1 |
| Bathla, L | 1 |
| Govindarajan, V | 1 |
| Thomas, P | 4 |
| Loggie, BW | 1 |
| Ji, ZQ | 1 |
| Huang, XE | 1 |
| Liu, J | 2 |
| Wang, L | 1 |
| Tang, JH | 1 |
| Yoshioka, M | 1 |
| Shibata, S | 1 |
| Uchinami, H | 1 |
| Watanabe, G | 1 |
| Miyazawa, H | 1 |
| Iida, M | 1 |
| Yoshida, M | 2 |
| Yoshioka, T | 2 |
| Nanjo, H | 1 |
| Yamamoto, Y | 3 |
| Ko, JC | 5 |
| Wang, TJ | 2 |
| Chang, PY | 2 |
| Syu, JJ | 1 |
| Chen, JC | 2 |
| Chen, CY | 1 |
| Jian, YT | 1 |
| Jian, YJ | 1 |
| Zheng, HY | 2 |
| Chen, WC | 2 |
| Lin, YW | 6 |
| Huang, Y | 1 |
| Alzahrani, NA | 1 |
| Liauw, W | 1 |
| Morris, DL | 1 |
| Horinouchi, H | 1 |
| Goto, Y | 1 |
| Kanda, S | 1 |
| Fujiwara, Y | 3 |
| Nokihara, H | 1 |
| Yamamoto, N | 4 |
| Sumi, M | 1 |
| Tamura, T | 5 |
| Ohe, Y | 5 |
| Torii, I | 1 |
| Tateishi, U | 1 |
| Terauchi, T | 1 |
| Inoue, T | 4 |
| Shen, CY | 1 |
| Chen, LH | 1 |
| Lin, YF | 1 |
| Lai, LC | 1 |
| Chuang, EY | 1 |
| Tsai, MH | 1 |
| Prasad, P | 1 |
| Cai, P | 1 |
| Shan, D | 1 |
| Ciou, SC | 1 |
| Cheng, CM | 2 |
| Wang, LH | 1 |
| Hong, JH | 1 |
| Jheng, MY | 1 |
| Ling, ST | 1 |
| Teo, FS | 1 |
| Hsu, AA | 1 |
| Thirugnanam, A | 1 |
| Carretta, A | 1 |
| Ciriaco, P | 2 |
| Melloni, G | 1 |
| Sayed, I | 1 |
| Bandiera, A | 1 |
| Ferla, L | 1 |
| Puglisi, A | 1 |
| Zannini, P | 1 |
| Ota, K | 4 |
| Kurita, S | 2 |
| Nishimura, M | 5 |
| Ogawa, M | 3 |
| Kamei, Y | 1 |
| Imai, K | 1 |
| Ariyoshi, Y | 5 |
| Kataoka, K | 1 |
| Murakami, M | 2 |
| Oyama, A | 2 |
| Hoshino, A | 1 |
| Amo, H | 1 |
| Kato, T | 2 |
| Jenkins, P | 1 |
| Anderson, S | 2 |
| Wronski, S | 1 |
| Ashton, A | 1 |
| Shi, D | 1 |
| Shi, G | 1 |
| Huang, G | 1 |
| Zhang, J | 2 |
| Lartigau, E | 1 |
| Loriot, Y | 1 |
| Mordant, P | 1 |
| Deutsch, E | 1 |
| Favaretto, A | 3 |
| Pasello, G | 1 |
| Loreggian, L | 1 |
| Breda, C | 1 |
| Braccioni, F | 1 |
| Marulli, G | 1 |
| Stragliotto, S | 1 |
| Magro, C | 1 |
| Sotti, G | 1 |
| Rea, F | 1 |
| Dai, CH | 1 |
| Yu, LC | 1 |
| Chen, P | 1 |
| Li, XQ | 1 |
| Shi, SB | 1 |
| Wu, JR | 1 |
| Su, YJ | 1 |
| Tsai, MS | 3 |
| Kuo, YH | 3 |
| Chiu, YF | 3 |
| Lin, ST | 1 |
| Nagano, T | 1 |
| Kim, YH | 1 |
| Goto, K | 2 |
| Kubota, K | 4 |
| Ohmatsu, H | 2 |
| Niho, S | 2 |
| Yoh, K | 1 |
| Naito, Y | 2 |
| Saijo, N | 20 |
| Nishiwaki, Y | 5 |
| Watanabe, K | 5 |
| Otake, T | 1 |
| Yasuda, M | 1 |
| Takenoshita, S | 1 |
| Lustberg, MB | 1 |
| Bekaii-Saab, T | 1 |
| Young, D | 1 |
| Otterson, G | 1 |
| Burak, W | 1 |
| Abbas, A | 1 |
| McCracken-Bussa, B | 1 |
| Lustberg, ME | 1 |
| Villalona-Calero, MA | 1 |
| Segawa, Y | 2 |
| Kiura, K | 4 |
| Takigawa, N | 2 |
| Kamei, H | 1 |
| Harita, S | 1 |
| Hiraki, S | 3 |
| Watanabe, Y | 3 |
| Sugimoto, K | 2 |
| Shibayama, T | 1 |
| Yonei, T | 1 |
| Ueoka, H | 2 |
| Takemoto, M | 2 |
| Kanazawa, S | 2 |
| Takata, I | 1 |
| Nogami, N | 1 |
| Hotta, K | 2 |
| Hiraki, A | 1 |
| Tabata, M | 2 |
| Matsuo, K | 2 |
| Tanimoto, M | 2 |
| Nakagawa, K | 2 |
| Nishimura, Y | 4 |
| Tsujino, K | 1 |
| Satouchi, M | 1 |
| Kudo, S | 3 |
| Hida, T | 1 |
| Kawahara, M | 8 |
| Takeda, K | 1 |
| Katakami, N | 2 |
| Sawa, T | 2 |
| Yokota, S | 2 |
| Seto, T | 2 |
| Imamura, F | 1 |
| Saka, H | 2 |
| Iwamoto, Y | 1 |
| Semba, H | 2 |
| Chiba, Y | 1 |
| Uejima, H | 1 |
| Fukuoka, M | 12 |
| Noura, S | 1 |
| Ohue, M | 1 |
| Shingai, T | 1 |
| Kano, S | 1 |
| Ohigashi, H | 1 |
| Yano, M | 1 |
| Ishikawa, O | 1 |
| Takenaka, A | 1 |
| Murata, K | 1 |
| Kameyama, M | 1 |
| Sakamoto, H | 1 |
| Amikura, K | 1 |
| Tanaka, Y | 2 |
| Kawashima, Y | 1 |
| Yatsuoka, T | 1 |
| Yamagata, Y | 1 |
| Yamaura, T | 1 |
| Yokoyama, Y | 1 |
| Akiyama, H | 1 |
| Nakajima, T | 2 |
| Tamaoki, A | 1 |
| Tokuda, Y | 1 |
| Nagata, T | 3 |
| Gemba, K | 1 |
| Moritaka, T | 1 |
| Horita, N | 1 |
| Takeda, H | 1 |
| Okimoto, N | 1 |
| Shinkai, T | 11 |
| Yan, D | 1 |
| Zhou, CW | 1 |
| Liu, DZ | 1 |
| Chen, Y | 1 |
| Zeng, HY | 1 |
| Li, H | 1 |
| Weng, SH | 2 |
| Sirbu, BM | 1 |
| Lachmayer, SJ | 1 |
| Wülfing, V | 1 |
| Marten, LM | 1 |
| Clarkson, KE | 1 |
| Lee, LW | 1 |
| Gheorghiu, L | 2 |
| Zou, L | 2 |
| Powell, SN | 1 |
| Dahm-Daphi, J | 2 |
| Willers, H | 2 |
| Li, M | 1 |
| Wu, Y | 1 |
| Qiu, Y | 1 |
| Yao, Z | 1 |
| Liu, S | 1 |
| Liu, Y | 1 |
| Shi, J | 1 |
| Zheng, D | 1 |
| Chen, HJ | 1 |
| Giner, V | 4 |
| Berchier, MC | 2 |
| Lewin, D | 1 |
| Meert, AP | 3 |
| Bosschaerts, T | 1 |
| Leclercq, N | 2 |
| Mouillet, G | 1 |
| Monnet, E | 1 |
| Milleron, B | 5 |
| Puyraveau, M | 2 |
| Quoix, E | 5 |
| David, P | 1 |
| Ducoloné, A | 1 |
| Molinier, O | 1 |
| Zalcman, G | 1 |
| Depierre, A | 6 |
| Westeel, V | 4 |
| Li, C | 1 |
| Yang, W | 1 |
| Gai, X | 1 |
| Zhang, Y | 1 |
| Li, Y | 1 |
| Fu, H | 1 |
| Vitale, FV | 1 |
| Malaponte, E | 1 |
| Calì, S | 1 |
| Antonelli, G | 1 |
| Panebianco, V | 1 |
| Blandino, R | 1 |
| Ferraù, F | 1 |
| Smith, D | 1 |
| Dahan, L | 1 |
| Michel, C | 1 |
| Perrier, H | 1 |
| Mari, V | 1 |
| Seitz, JF | 1 |
| Chamorey, E | 1 |
| Birkelbach, M | 1 |
| Ferraiolo, N | 1 |
| Pfäffle, HN | 1 |
| Daly, B | 1 |
| Ebright, MI | 1 |
| Spencer, C | 1 |
| O'Hara, C | 1 |
| Whetstine, JR | 1 |
| Benes, CH | 1 |
| Sequist, LV | 1 |
| Kachnic, LA | 1 |
| Gebbia, V | 4 |
| Galetta, D | 1 |
| Riccardi, F | 1 |
| Gridelli, C | 6 |
| Durini, E | 1 |
| Borsellino, N | 1 |
| Gebbia, N | 2 |
| Valdesi, M | 1 |
| Caruso, M | 1 |
| Valenza, R | 1 |
| Pezzella, G | 1 |
| Colucci, G | 2 |
| Billingham, LJ | 3 |
| Bathers, S | 1 |
| Burton, A | 1 |
| Bryan, S | 1 |
| Cullen, MH | 6 |
| Johnstone, DW | 1 |
| Byhardt, RW | 1 |
| Ettinger, D | 1 |
| Scott, CB | 1 |
| Kameyama, K | 1 |
| Huang, CL | 1 |
| Hayashi, E | 1 |
| Liu, D | 1 |
| Okamoto, T | 3 |
| Yokomise, H | 1 |
| Molinaro, G | 1 |
| Adam, A | 1 |
| Lepage, Y | 1 |
| Hammerschmidt, D | 1 |
| Koenigbauer, U | 1 |
| Eastlund, T | 1 |
| Crinò, L | 9 |
| Lin, YC | 1 |
| Lin, Y | 1 |
| Lin, W | 1 |
| Du, CW | 1 |
| Wu, MY | 1 |
| Li, DR | 1 |
| Qiang, E | 1 |
| Wang, SP | 1 |
| Liu, SJ | 1 |
| Yiao, J | 1 |
| Xiao, QM | 1 |
| Zhang, WD | 1 |
| Zhou, JH | 1 |
| Mornex, F | 1 |
| Jiang, CM | 1 |
| Pang, MR | 1 |
| Gong, LY | 1 |
| Yu, RC | 2 |
| Tang, WJ | 1 |
| Duan, P | 1 |
| Wang, ZM | 1 |
| Yamaguchi, M | 1 |
| Fukuyama, Y | 1 |
| Ichinose, Y | 3 |
| Kwon, MR | 1 |
| Jeong, TY | 1 |
| Yuh, YJ | 1 |
| Kim, SR | 1 |
| Tao, K | 1 |
| Zhou, X | 1 |
| Grundmann, JU | 1 |
| Weisshaar, E | 1 |
| Franke, I | 1 |
| Bonnekoh, B | 1 |
| Gollnick, H | 1 |
| Danson, S | 1 |
| Middleton, MR | 1 |
| O'Byrne, KJ | 1 |
| Clemons, M | 1 |
| Ranson, M | 1 |
| Hassan, J | 1 |
| Anderson, H | 2 |
| Burt, PA | 1 |
| Fairve-Finn, C | 1 |
| Stout, R | 1 |
| Dowd, I | 1 |
| Ashcroft, L | 4 |
| Beresford, C | 1 |
| Thatcher, N | 6 |
| Hori, K | 1 |
| Saito, S | 1 |
| Sato, Y | 1 |
| Akita, H | 1 |
| Kawaguchi, T | 2 |
| Sugiyama, K | 1 |
| Sato, H | 2 |
| Konovalova, NP | 1 |
| ASHIGAWA, K | 1 |
| HATTORI, T | 1 |
| OKADA, K | 1 |
| LANGDON, EA | 1 |
| OTTOMAN, RE | 1 |
| ROCHLIN, DB | 1 |
| SMART, CR | 1 |
| KANAGAMI, H | 1 |
| NIITANI, K | 1 |
| KATSURA, T | 1 |
| MYHRE, K | 1 |
| FJAERLI, J | 1 |
| SULLIVAN, RD | 1 |
| ZUREK, WZ | 1 |
| EBINA, R | 1 |
| KANNO, I | 1 |
| UMEHARA, E | 1 |
| HASUIKE, T | 1 |
| KANABUCHI, I | 1 |
| SATO, K | 2 |
| KONDO, S | 1 |
| MUNAKATA, K | 1 |
| ITO, Y | 1 |
| INOOKA, SI | 1 |
| KATAKURA, Y | 1 |
| SATO, M | 3 |
| AOKI, Y | 1 |
| SUZUKI, M | 1 |
| KOIZUMI, A | 1 |
| KOBAYASHI, T | 7 |
| SUZUKI, H | 1 |
| Scagliotti, GV | 2 |
| Fossati, R | 1 |
| Torri, V | 1 |
| Giaccone, G | 3 |
| Silvano, G | 1 |
| Martelli, M | 1 |
| Clerici, M | 3 |
| Cognetti, F | 2 |
| Tonato, M | 5 |
| Yoshida, T | 3 |
| Ishiguro, T | 1 |
| Ogawara, M | 4 |
| Yamamoto, S | 1 |
| Maeda, H | 3 |
| Asamoto, H | 2 |
| Paccagnella, A | 2 |
| Oniga, F | 2 |
| Barbieri, F | 1 |
| Ceresoli, G | 1 |
| Torri, W | 1 |
| Villa, E | 1 |
| Verusio, C | 1 |
| Cetto, GL | 1 |
| Santo, A | 2 |
| De Pangher, V | 1 |
| Artioli, F | 1 |
| Cacciani, GC | 2 |
| Parodi, G | 1 |
| Soresi, F | 1 |
| Ghi, MG | 1 |
| Morabito, A | 2 |
| Biason, R | 1 |
| Giusto, M | 1 |
| Mosconi, P | 1 |
| Chiarion Sileni, V | 1 |
| Kitai, T | 1 |
| Nomura, A | 1 |
| Miki, A | 1 |
| Ukikusa, M | 1 |
| Kojima, N | 1 |
| Nishikawa, S | 1 |
| Ishigaki, T | 1 |
| Todo, G | 1 |
| Jenkins, DE | 1 |
| Oei, Y | 1 |
| Hornig, YS | 1 |
| Yu, SF | 1 |
| Dusich, J | 1 |
| Purchio, T | 1 |
| Contag, PR | 1 |
| Cordes, N | 1 |
| Beinke, C | 1 |
| Plasswilm, L | 1 |
| van Beuningen, D | 1 |
| Van Houtte, P | 2 |
| Lecomte, J | 2 |
| Thiriaux, J | 4 |
| Efremidis, A | 2 |
| Koumakis, G | 3 |
| Richez, M | 2 |
| Corhay, JL | 2 |
| Wackenier, P | 2 |
| Lothaire, P | 2 |
| Mommen, P | 4 |
| Ninane, V | 5 |
| Kornek, GV | 1 |
| Schuell, B | 1 |
| Laengle, F | 1 |
| Gruenberger, T | 1 |
| Penz, M | 1 |
| Karall, K | 1 |
| Depisch, D | 1 |
| Lang, F | 1 |
| Scheithauer, W | 1 |
| Varrassi, G | 1 |
| Ciccozzi, A | 1 |
| Marinangeli, F | 1 |
| Pozone, T | 1 |
| Piroli, A | 1 |
| Marsili, I | 1 |
| Paladini, A | 1 |
| Gao, JF | 1 |
| Li, CS | 1 |
| Zhang, BC | 1 |
| Du, GZ | 1 |
| Zhang, XH | 1 |
| Wang, J | 1 |
| Zhu, YZ | 1 |
| Ou, WL | 1 |
| Yang, B | 1 |
| Jin, ZH | 1 |
| Matsumoto, H | 1 |
| Hayashi, S | 1 |
| Hatashita, M | 1 |
| Ohtsubo, T | 1 |
| Shioura, H | 1 |
| Kitai, R | 1 |
| Kano, E | 1 |
| VanHoutte, P | 1 |
| Sigounas, G | 1 |
| Sallah, S | 1 |
| Sigounas, VY | 1 |
| Lee, CS | 1 |
| Park, SY | 1 |
| Ko, HH | 1 |
| Han, ES | 1 |
| Peer, D | 1 |
| Dekel, Y | 1 |
| Melikhov, D | 1 |
| Margalit, R | 1 |
| Rudd, RM | 3 |
| Gower, NH | 2 |
| Spiro, SG | 3 |
| Eisen, TG | 1 |
| Harper, PG | 2 |
| Littler, JA | 1 |
| Hatton, M | 1 |
| Johnson, PW | 1 |
| Martin, WM | 1 |
| Rankin, EM | 1 |
| James, LE | 1 |
| Gregory, WM | 1 |
| Qian, W | 1 |
| Lee, SM | 1 |
| Tian, M | 1 |
| Higuchi, T | 1 |
| Oriuchi, N | 1 |
| Endo, K | 3 |
| Vogl, TJ | 1 |
| Wetter, A | 1 |
| Lindemayr, S | 1 |
| Zangos, S | 1 |
| Kaira, K | 2 |
| Takise, A | 2 |
| Kobayashi, G | 1 |
| Utsugi, M | 1 |
| Horie, T | 2 |
| Mori, T | 2 |
| Imai, H | 1 |
| Inazawa, M | 1 |
| Mori, M | 2 |
| Moro-Sibilot, D | 3 |
| Mercier, M | 1 |
| Breton, JL | 2 |
| Debieuvre, D | 1 |
| Richard, P | 1 |
| Haller, MA | 1 |
| Herman, D | 1 |
| Level, MC | 2 |
| Lebas, FX | 2 |
| Yuan, JB | 1 |
| Liu, ZX | 1 |
| Liu, C | 1 |
| Park, JH | 2 |
| Lee, CT | 2 |
| Lee, HW | 1 |
| Baek, HJ | 2 |
| Zo, JI | 2 |
| Shim, YM | 2 |
| Stephens, RJ | 1 |
| Girling, DJ | 1 |
| Hopwood, P | 1 |
| Yamazaki, S | 2 |
| Sekine, I | 1 |
| Matsuno, Y | 1 |
| Takei, H | 1 |
| Kunitoh, H | 1 |
| Kodama, T | 2 |
| Asamura, H | 1 |
| Tsuchiya, R | 1 |
| Sawada, T | 1 |
| Hirose, K | 1 |
| Braun, D | 2 |
| Lebeau, B | 5 |
| Govindan, R | 1 |
| Tho, LM | 1 |
| Ferry, DR | 2 |
| Yamanaka, T | 1 |
| Sano, O | 1 |
| Okabe, K | 5 |
| Beppu, T | 1 |
| Baba, H | 2 |
| Giuliani, F | 1 |
| Molica, S | 1 |
| Maiello, E | 1 |
| Battaglia, C | 1 |
| Di Bisceglie, M | 1 |
| Vinciarelli, G | 1 |
| Shintani, S | 1 |
| Hino, S | 1 |
| Nakashiro, K | 1 |
| Hamakawa, H | 1 |
| Feliu, J | 4 |
| Martín, G | 1 |
| Castro, J | 1 |
| Sundlov, A | 1 |
| Rodriguez-Jaráiz, A | 1 |
| Casado, E | 1 |
| Lomas, M | 1 |
| Madroñal, C | 1 |
| Galán, A | 1 |
| Belda, C | 1 |
| Gonzalez-Barón, M | 1 |
| Booton, R | 3 |
| Lorigan, P | 1 |
| Baka, S | 1 |
| Nicolson, M | 1 |
| O'Brien, M | 1 |
| Dunlop, D | 1 |
| O'Byrne, K | 1 |
| Laurence, V | 1 |
| Snee, M | 2 |
| Dark, G | 1 |
| Takeda, S | 1 |
| Funakoshi, Y | 1 |
| Kadota, Y | 1 |
| Koma, M | 1 |
| Kawamura, S | 1 |
| Matsubara, Y | 1 |
| Cok, G | 1 |
| Göksel, T | 1 |
| Soyer, S | 1 |
| Atil, H | 1 |
| Güzelant, A | 1 |
| Aysan, T | 1 |
| Wang, X | 1 |
| Lin, CJ | 1 |
| Couch, FJ | 1 |
| Fei, P | 1 |
| Tamura, M | 1 |
| Doba, S | 1 |
| Funaki, K | 1 |
| Sasaki, S | 1 |
| Michiwa, Y | 2 |
| Kurosaka, Y | 1 |
| Takekawa, S | 1 |
| Kiriyama, M | 1 |
| Kojima, Y | 1 |
| Kita, T | 1 |
| Kawashima, A | 1 |
| Wakiyama, S | 1 |
| Shirabe, K | 1 |
| Nagaie, T | 1 |
| Babiak, A | 1 |
| Hetzel, J | 1 |
| Godde, F | 1 |
| König, HH | 1 |
| Pietsch, M | 1 |
| Hetzel, M | 1 |
| Booten, R | 1 |
| Ward, T | 2 |
| Heighway, J | 2 |
| Morris, J | 2 |
| Liu, YL | 1 |
| Song, XR | 1 |
| Wang, XW | 1 |
| Wei, L | 1 |
| Li, DP | 1 |
| Okamoto, H | 1 |
| Fennell, DA | 1 |
| Steele, JP | 1 |
| Shamash, J | 1 |
| Slater, SE | 1 |
| Sheaff, MT | 1 |
| Wells, P | 1 |
| Stebbing, J | 1 |
| Kropf, C | 1 |
| Merk, T | 1 |
| Hombach, V | 1 |
| Krüger, S | 1 |
| Rolski, J | 1 |
| Zemełka, T | 1 |
| Jasiówka, M | 1 |
| Czyzewicz, G | 1 |
| Kojs-Pasińska, E | 1 |
| Akamine, S | 1 |
| Nakamura, Y | 4 |
| Oka, T | 1 |
| Soda, H | 1 |
| Taniguchi, H | 1 |
| Fukuda, M | 1 |
| Minami, H | 2 |
| Nagashima, S | 1 |
| Ashizawa, K | 1 |
| Goya, T | 1 |
| Oka, M | 1 |
| Kohno, S | 1 |
| Tagawa, T | 1 |
| Nagayasu, T | 1 |
| Gourcerol, D | 1 |
| Kotsori, K | 1 |
| Cuddihy, AR | 1 |
| Jalali, F | 1 |
| Coackley, C | 1 |
| Bristow, RG | 1 |
| Niell, HB | 4 |
| Griffin, JP | 2 |
| West, WH | 1 |
| Neely, CL | 1 |
| Daniels, JR | 1 |
| Chak, LY | 2 |
| Sikic, BI | 2 |
| Lockbaum, P | 1 |
| Kohler, M | 1 |
| Carter, SK | 1 |
| Reynolds, R | 1 |
| Bohnen, R | 1 |
| Gandara, D | 1 |
| Yu, J | 1 |
| Joss, RA | 2 |
| Obrecht, JP | 1 |
| Senn, HJ | 1 |
| Alberto, P | 2 |
| Sauter, C | 1 |
| Cavalli, F | 2 |
| Yokoyama, K | 4 |
| Takashima, T | 2 |
| Nozaki, M | 2 |
| Kaito, S | 1 |
| Shimomura, T | 1 |
| Takeuchi, A | 1 |
| Kurokawa, A | 2 |
| Fujii, M | 4 |
| Ishikawa, M | 2 |
| Toki, H | 4 |
| Fujita, Y | 1 |
| Araki, Y | 1 |
| Ishimitsu, T | 1 |
| Goto, T | 1 |
| Furuta, I | 1 |
| Urata, A | 3 |
| Fukushima, M | 1 |
| Okuma, K | 1 |
| Tominaga, K | 8 |
| Eguchi, K | 10 |
| Shimizu, E | 13 |
| Takahashi, K | 4 |
| Sasaki, Y | 9 |
| Ohkura, H | 1 |
| Hayashida, S | 1 |
| Takada, M | 9 |
| Tamai, S | 1 |
| Negoro, S | 7 |
| Matsui, K | 6 |
| Ryu, S | 4 |
| Sakai, N | 3 |
| Sakaguchi, K | 1 |
| Schulz, V | 1 |
| Weigand, H | 1 |
| Ferlinz, R | 1 |
| Raut, Y | 1 |
| Huu, N | 1 |
| Clavier, J | 3 |
| Guillerm, D | 1 |
| Barra, JA | 1 |
| Hisa, T | 1 |
| Sawano, T | 1 |
| Sakai, K | 1 |
| Kitamura, S | 1 |
| Matsushita, N | 1 |
| Kokura, M | 1 |
| Satake, H | 1 |
| Kawakami, I | 1 |
| Saito, H | 3 |
| Nomura, F | 2 |
| Kawatsu, H | 1 |
| Sakai, S | 3 |
| Shimokata, K | 3 |
| Shimabukuro, Z | 2 |
| Iwashita, K | 1 |
| Niitani, H | 3 |
| Ritch, PS | 1 |
| Louie, AC | 1 |
| Kimura, H | 6 |
| Yamaguchi, Y | 6 |
| Kadoyama, C | 1 |
| Sato, N | 1 |
| Fujisawa, T | 2 |
| Bakowski, MT | 1 |
| Crouch, JC | 1 |
| Kaneto, E | 1 |
| Sasaki, H | 4 |
| Tamura, I | 1 |
| Kurimura, O | 1 |
| Kurimura, T | 1 |
| Seki, S | 1 |
| Salvati, F | 2 |
| Cruciani, AR | 1 |
| De Marinis, A | 1 |
| Nunziati, F | 1 |
| Portalone, L | 4 |
| Spencer, HJ | 1 |
| Ekholm, S | 1 |
| Albrechtsson, U | 1 |
| Tylén, U | 2 |
| Uchida, A | 2 |
| Micksche, M | 1 |
| Wakui, A | 1 |
| Taguchi, T | 3 |
| Shibuya, M | 4 |
| Takizawa, T | 2 |
| Fujioka, Y | 1 |
| Hoshi, A | 4 |
| Hamazoe, R | 1 |
| Koga, S | 2 |
| Maeta, M | 2 |
| Shimizu, N | 1 |
| Sumi, K | 1 |
| Oda, M | 3 |
| Karino, T | 1 |
| Yamane, T | 1 |
| Kanayama, H | 1 |
| Osaki, Y | 1 |
| Stewart, DJ | 1 |
| Maroun, JA | 1 |
| Young, V | 1 |
| Crook, AF | 1 |
| Hopkins, HS | 1 |
| Yan, RC | 1 |
| Richard, MT | 1 |
| Hugenholtz, H | 1 |
| Bélanger, R | 1 |
| Heringer, R | 1 |
| Logothetis, CJ | 2 |
| Samuels, ML | 1 |
| von Eschenbach, AC | 1 |
| Trindade, A | 1 |
| Ogden, S | 1 |
| Grant, C | 1 |
| Johnson, DE | 1 |
| Buice, RG | 2 |
| Sidhu, P | 2 |
| Gurley, BJ | 2 |
| Kakizoe, T | 1 |
| Matsumoto, K | 2 |
| Nishio, Y | 1 |
| Ohtani, M | 1 |
| Miyazawa, N | 2 |
| Orita, K | 2 |
| Miwa, H | 1 |
| Yamashita, H | 1 |
| Kurimoto, M | 1 |
| Ninomiya, K | 1 |
| Sekido, S | 1 |
| Araki, T | 1 |
| Pedersen, JE | 1 |
| Barron, G | 1 |
| Bradner, WT | 1 |
| Rose, WC | 1 |
| Schurig, JE | 1 |
| Schlein, A | 1 |
| Huftalen, JB | 1 |
| Tabuchi, Y | 1 |
| Nakae, S | 1 |
| Imanishi, K | 1 |
| Kawasaki, H | 1 |
| Ohyama, T | 1 |
| Murayama, Y | 1 |
| Takiguchi, Y | 1 |
| Saitoh, Y | 3 |
| Chahinian, AP | 2 |
| Green, G | 1 |
| Holland, JF | 2 |
| Mitsuhata, N | 2 |
| Hino, N | 1 |
| Tagusagawa, Y | 1 |
| Suga, K | 2 |
| Nishigaki, S | 1 |
| Doyle, LA | 1 |
| Ihde, DC | 2 |
| Carney, DN | 1 |
| Bunn, PA | 2 |
| Cohen, MH | 1 |
| Matthews, MJ | 1 |
| Puffenbarger, R | 1 |
| Cordes, RS | 1 |
| Minna, JD | 1 |
| Meguro, S | 2 |
| Chinen, T | 2 |
| Yamazaki, H | 2 |
| Kuraishi, Y | 2 |
| Abe, M | 1 |
| Isogai, Y | 2 |
| Nishi, I | 1 |
| Yokoyama, T | 1 |
| Nakao, I | 1 |
| Harashima, S | 1 |
| Ohashi, Y | 2 |
| Kanko, T | 1 |
| Saito, T | 2 |
| Nomori, H | 1 |
| Garcia-Herreros, P | 1 |
| Imai, R | 1 |
| Morimoto, M | 2 |
| Marumo, H | 1 |
| Tsuruo, T | 3 |
| Inaba, M | 3 |
| Tsukagoshi, S | 2 |
| Sakurai, Y | 1 |
| Carter, WH | 1 |
| Wampler, GL | 1 |
| Stablein, DM | 1 |
| Campbell, ED | 1 |
| Takeda, J | 2 |
| Kakegawa, T | 2 |
| Edakuni, S | 1 |
| Eto, M | 1 |
| Hashimoto, K | 3 |
| Abe, H | 1 |
| Takeuchi, K | 2 |
| Isobe, M | 2 |
| Matsuo, S | 1 |
| Machida, T | 1 |
| Masuda, F | 1 |
| Yamamoto, M | 2 |
| Souquet, PJ | 2 |
| Fournel, P | 1 |
| Jorda, M | 1 |
| Laennec, E | 1 |
| Piperno, D | 1 |
| Trillet, V | 1 |
| Rebattu, P | 1 |
| Bernard, JP | 1 |
| Carles, J | 2 |
| Rosell, R | 6 |
| Ariza, A | 1 |
| Pellicer, I | 1 |
| Sanchez, JJ | 1 |
| Fernandez-Vasalo, G | 1 |
| Abad, A | 2 |
| Barnadas, A | 2 |
| Kakinuma, H | 1 |
| Matsuda, Y | 1 |
| Tummarello, D | 2 |
| Graziano, F | 2 |
| Isidori, P | 2 |
| Cellerino, R | 2 |
| Ardizzoni, A | 2 |
| Addamo, GF | 1 |
| Baldini, E | 2 |
| Borghini, U | 2 |
| De Marinis, F | 3 |
| Lionetto, R | 1 |
| Conte, PF | 1 |
| Bruzzi, P | 1 |
| Pennucci, MC | 2 |
| Rendina, EA | 2 |
| Venuta, F | 2 |
| De Giacomo, T | 2 |
| Della Rocca, G | 1 |
| Flaishman, I | 1 |
| Baroni, C | 1 |
| Cortesi, E | 3 |
| Bonsignore, G | 1 |
| Ricci, C | 2 |
| Figoli, F | 2 |
| Barduagni, M | 1 |
| Carlini, P | 2 |
| Ceci, G | 2 |
| Carpi, A | 2 |
| Santini, A | 2 |
| Di Costanzo, F | 5 |
| Molina, F | 2 |
| Moreno, I | 3 |
| Martínez, E | 1 |
| Pifarré, A | 1 |
| Font, A | 2 |
| Li, S | 1 |
| Skacel, Z | 1 |
| Gómez-Codina, J | 3 |
| Camps, C | 3 |
| Milroy, R | 1 |
| Macbeth, F | 1 |
| Hyogo, H | 1 |
| Ito, K | 2 |
| Kido, S | 1 |
| Yamamoto, K | 3 |
| Kida, M | 1 |
| Matsuda, M | 2 |
| Kojima, K | 1 |
| Matsuura, M | 1 |
| Nakajima, N | 1 |
| Akiyama, J | 1 |
| Boni, C | 1 |
| Thongprasert, S | 2 |
| Sanquanmitr, P | 1 |
| Takano, Y | 1 |
| Oida, K | 1 |
| Kohri, Y | 1 |
| Taguchi, Y | 1 |
| Tomii, K | 1 |
| Matsumura, Y | 1 |
| Mino, M | 1 |
| Gohma, I | 1 |
| Kobashi, Y | 1 |
| Wang, GM | 1 |
| Chen, CH | 2 |
| Sun, GZ | 1 |
| Dirix, L | 1 |
| Catimel, G | 1 |
| Koier, I | 1 |
| Provè, A | 1 |
| Schrijvers, D | 1 |
| Joossens, E | 1 |
| De Bruijn, E | 1 |
| Ardiet, C | 1 |
| Evene, E | 1 |
| Dumortier, A | 1 |
| Maeda, M | 1 |
| Ando, M | 1 |
| Oshita, F | 2 |
| Shiraishi, J | 1 |
| Katsumata, N | 1 |
| Mirimanoff, RO | 1 |
| Mermillod, B | 1 |
| Leyvraz, S | 1 |
| Nagy-Mignotte, H | 1 |
| Bolla, M | 1 |
| Wellmann, D | 1 |
| Moro, D | 2 |
| Brambilla, E | 1 |
| Shibata, K | 2 |
| Kasahara, K | 2 |
| Bando, T | 2 |
| Nakatsumi, Y | 1 |
| Fujimura, M | 2 |
| Matsuda, T | 2 |
| Peng, XM | 1 |
| Rao, XQ | 1 |
| Broder, LE | 2 |
| Sridhar, KS | 2 |
| Selawry, OS | 2 |
| Charyulu, KN | 2 |
| Rao, RK | 2 |
| Saldana, MJ | 2 |
| Donnelly, EJ | 1 |
| Raub, WA | 1 |
| Nagai, K | 1 |
| Nishiyama, H | 1 |
| Hojo, H | 1 |
| Matsumoto, T | 3 |
| Lee, LN | 2 |
| Yang, PC | 2 |
| Chang, DB | 2 |
| Yu, CJ | 2 |
| Liaw, YS | 1 |
| Wu, RG | 1 |
| Luh, KT | 2 |
| Rossi, A | 3 |
| Palazzolo, G | 3 |
| Pepe, R | 4 |
| Airoma, G | 4 |
| Incoronato, P | 3 |
| Bianco, AR | 3 |
| Liao, ML | 1 |
| Kodama, K | 2 |
| Doi, O | 1 |
| Higashiyama, M | 1 |
| Yokouchi, H | 1 |
| Kuriyama, K | 1 |
| González Barón, M | 3 |
| Espinosa, E | 1 |
| García Girón, C | 3 |
| Blanco, E | 1 |
| Garrido, P | 3 |
| Colmenarejo, A | 1 |
| Ordóñez, A | 3 |
| Moyano, A | 1 |
| de la Gándara, I | 1 |
| Fujita, M | 1 |
| Fujita, F | 1 |
| Inaba, H | 1 |
| Harada, M | 1 |
| Matsuzaki, G | 1 |
| Shinomiya, Y | 1 |
| Kurosawa, S | 1 |
| Ito, O | 1 |
| Takenoyama, M | 1 |
| Sumitika, H | 1 |
| Nomoto, K | 2 |
| Beall, HD | 1 |
| Mulcahy, RT | 1 |
| Siegel, D | 2 |
| Traver, RD | 1 |
| Gibson, NW | 2 |
| Ross, D | 2 |
| Chastang, C | 2 |
| Jacoulet, P | 1 |
| Paillot, N | 2 |
| Janicot, H | 2 |
| Lombard, JN | 1 |
| Maestre, J | 2 |
| Milla, A | 1 |
| Arcangeli, G | 1 |
| Zaniboni, A | 2 |
| Milano, S | 2 |
| Meriggi, F | 1 |
| Simoncini, E | 1 |
| Marpicati, P | 1 |
| Marini, G | 2 |
| Prewitt, TW | 1 |
| Matthews, W | 1 |
| Chaudhri, G | 1 |
| Pogrebniak, HW | 1 |
| Pass, HI | 1 |
| Dong, QG | 1 |
| Gong, LL | 1 |
| Wang, HJ | 1 |
| Wang, EZ | 1 |
| Kodama, I | 1 |
| Aoyagi, K | 1 |
| Tanaka, T | 1 |
| Kumegawa, H | 1 |
| Ohta, J | 1 |
| Maruiwa, M | 1 |
| Kofuji, K | 1 |
| Ogura, T | 3 |
| Sone, S | 5 |
| Nakayama, T | 1 |
| Doi, H | 1 |
| Takishita, Y | 1 |
| Bando, H | 1 |
| Kobayashi, M | 2 |
| Kimura, K | 2 |
| Hesketh, PJ | 2 |
| Tansan, S | 1 |
| Caguioa, PB | 1 |
| Hesketh, A | 1 |
| Blanchard, R | 1 |
| DiMartino, N | 1 |
| Carney, D | 1 |
| Uchida, T | 1 |
| Nakagawaji, K | 1 |
| Kojima, H | 1 |
| Tokumaru, T | 1 |
| Imaizumi, M | 1 |
| Abe, T | 1 |
| Folman, RS | 2 |
| Spain, RC | 2 |
| Martini, N | 4 |
| Kris, MG | 5 |
| Flehinger, BJ | 1 |
| Gralla, RJ | 4 |
| Bains, MS | 2 |
| Burt, ME | 2 |
| Heelan, R | 1 |
| McCormack, PM | 2 |
| Pisters, KM | 3 |
| Rigas, JR | 1 |
| Artal, A | 2 |
| Berrocal, A | 1 |
| Barón, JM | 1 |
| Zaman, MB | 2 |
| Heelan, RT | 3 |
| Murren, JR | 1 |
| Ganpule, S | 1 |
| Papac, R | 1 |
| Son, YH | 1 |
| Peschel, RE | 1 |
| Durivage, H | 1 |
| Buzaid, AC | 1 |
| Lamb, L | 1 |
| Makuch, R | 1 |
| Hait, WN | 1 |
| Kleisbauer, JP | 2 |
| Perol, M | 1 |
| Taytard, A | 2 |
| Poirier, R | 2 |
| Le Caer, H | 1 |
| Guerin, JC | 1 |
| Bonnaud, F | 2 |
| Balmes, P | 1 |
| Carles, P | 1 |
| Tsumura, I | 2 |
| Kikkawa, N | 2 |
| Xing, FY | 1 |
| Liu, WH | 1 |
| Dong, W | 1 |
| Zhang, SL | 1 |
| Gu, BW | 1 |
| Okazaki, K | 1 |
| Naito, H | 1 |
| Wu, JT | 1 |
| Tamura, S | 2 |
| Maehara, Y | 2 |
| Takeuchi, H | 1 |
| Inutsuka, S | 1 |
| Kohnoe, S | 1 |
| Sugimachi, K | 1 |
| Ohmori, T | 1 |
| Podack, ER | 1 |
| Nishio, K | 3 |
| Takahashi, M | 1 |
| Miyahara, Y | 1 |
| Takeda, Y | 1 |
| Kubota, N | 1 |
| Funayama, Y | 1 |
| Ogasawara, H | 1 |
| Ohira, T | 1 |
| Saiki, I | 1 |
| Yoneda, J | 1 |
| Kobayashi, H | 3 |
| Igarashi, Y | 1 |
| Komazawa, H | 1 |
| Ishizaki, Y | 1 |
| Kato, I | 1 |
| Azuma, I | 1 |
| Köpf-Maier, P | 1 |
| Sass, G | 1 |
| Numata, Y | 1 |
| Heki, U | 1 |
| Shirasaki, H | 1 |
| Tetef, M | 1 |
| Margolin, K | 1 |
| Ahn, C | 1 |
| Akman, S | 1 |
| Chow, W | 1 |
| Leong, L | 1 |
| Morgan, RJ | 1 |
| Raschko, J | 1 |
| Somlo, G | 1 |
| Doroshow, JH | 1 |
| Cetto, G | 1 |
| Fedeli, A | 1 |
| Rossi, G | 1 |
| Davydov, MI | 1 |
| Normantovich, VA | 1 |
| Polotskiĭ, BE | 1 |
| Ivshina, AV | 1 |
| Mkheidze, DM | 1 |
| Ferrigno, D | 2 |
| Buccheri, G | 2 |
| Hasegawa, T | 1 |
| Umeda, B | 1 |
| Adachi, S | 2 |
| Ishii, N | 1 |
| Takada, Y | 3 |
| Tsubota, N | 1 |
| Nakano, K | 2 |
| Tamura, R | 1 |
| Nakai, H | 1 |
| Fujimura, T | 2 |
| Yonemura, Y | 2 |
| Minami, M | 1 |
| Sato, T | 2 |
| Kawamura, T | 1 |
| Nojima, N | 1 |
| Kinami, S | 1 |
| Hirono, Y | 1 |
| Fushida, S | 2 |
| Nishimura, G | 2 |
| Noguchi, M | 1 |
| Miwa, K | 2 |
| Miyazaki, I | 1 |
| Shiobara, S | 1 |
| Festi, G | 1 |
| Lauro, S | 1 |
| Ossana, L | 1 |
| Sartore, F | 1 |
| DePoli, F | 1 |
| Fiorentino, MV | 1 |
| Zorzi, F | 1 |
| Ottoni, DB | 1 |
| Di Fabio, D | 1 |
| Mombelloni, G | 1 |
| Palmer, AJ | 1 |
| Brandt, A | 1 |
| Perrone, F | 1 |
| Palmeri, S | 2 |
| D'Aprile, M | 1 |
| Veltri, E | 1 |
| Russo, A | 2 |
| Scinto, AF | 1 |
| Natali, M | 1 |
| Leonardi, V | 1 |
| Gallo, C | 1 |
| De Placido, S | 1 |
| Ellis, PA | 1 |
| Luckitt, J | 1 |
| Treleaven, J | 1 |
| Smith, IE | 7 |
| Furuse, K | 7 |
| Kamimori, T | 1 |
| Kodama, N | 2 |
| Atagi, S | 2 |
| Naka, N | 2 |
| Akira, M | 2 |
| Kurokawa, H | 1 |
| Ishida, T | 2 |
| Fukuoka, K | 2 |
| Mosconi, AM | 2 |
| Li, JH | 1 |
| Yamano, Y | 1 |
| Yoshimura, A | 1 |
| Kudoh, S | 4 |
| Robinet, G | 1 |
| Vernenegre, A | 1 |
| Paillotin, D | 1 |
| Pommier De Santi, P | 1 |
| Barriere, JR | 1 |
| Pignon, T | 1 |
| Yamada, Y | 2 |
| Miyagawa, T | 1 |
| Toyoda, H | 1 |
| Uesato, K | 1 |
| Asanuma, F | 1 |
| Corgna, E | 3 |
| Porrozzi, S | 1 |
| Palladino, MA | 1 |
| Darwish, S | 3 |
| Minotti, V | 1 |
| Urabe, N | 1 |
| Momiki, S | 1 |
| Obata, S | 2 |
| Ogawa, T | 2 |
| Masuda, N | 7 |
| Takifuji, N | 5 |
| Kusunoki, Y | 4 |
| Masutani, M | 1 |
| Akusawa, H | 1 |
| Kadota, A | 1 |
| Ohchi, Y | 1 |
| Takahashi, N | 1 |
| Tanigawa, S | 1 |
| Koya, Y | 1 |
| Rossi, I | 1 |
| Nicoletti, G | 1 |
| Landuzzi, L | 1 |
| Frabetti, F | 1 |
| De Giovanni, C | 1 |
| Nanni, P | 1 |
| Musiani, P | 1 |
| Ferrantini, M | 1 |
| Belardelli, F | 1 |
| Lollini, PL | 1 |
| Ginopoulos, P | 1 |
| Spyropoulos, K | 1 |
| Kardamakis, D | 1 |
| Dougenis, D | 1 |
| Onyenadum, A | 1 |
| Gogos, CH | 1 |
| Solomou, E | 1 |
| Chrysanthopoulos, K | 1 |
| Middleton, GW | 1 |
| O'Brien, ME | 5 |
| Norton, A | 3 |
| Hickish, T | 1 |
| Priest, K | 2 |
| Spencer, L | 1 |
| Ashley, S | 4 |
| Ishihara, Y | 1 |
| Ichiwata, T | 1 |
| Kuramitsu, K | 2 |
| Yoneda, S | 2 |
| Ogata, T | 2 |
| Uchiyama, T | 1 |
| Yoshida, K | 1 |
| Tibaldi, C | 1 |
| Antilli, A | 1 |
| Barbera, S | 1 |
| Romano, F | 1 |
| Migliorino, MR | 1 |
| Noseda, MA | 1 |
| Crippa, M | 1 |
| Ferrara, G | 2 |
| Raimondi, M | 1 |
| Fioretti, M | 1 |
| Bandera, M | 1 |
| Galeasso, G | 1 |
| Lepidini, G | 1 |
| Sunseri, G | 1 |
| Lanfranco, C | 1 |
| Rinaldi, M | 2 |
| Rosso, R | 1 |
| Watanabe, H | 1 |
| Hirota, S | 2 |
| Soejima, T | 1 |
| Honda, K | 1 |
| Kono, K | 1 |
| Hishikawa, Y | 1 |
| Obayasi, K | 1 |
| Tsang, KW | 1 |
| Lam, WK | 3 |
| Ip, M | 3 |
| Hosoya, Y | 1 |
| Konishi, H | 1 |
| Horie, H | 1 |
| Ishizuka, T | 1 |
| Shitou, K | 1 |
| Kojima, M | 1 |
| Kashiwagi, H | 1 |
| Kanazawa, K | 1 |
| Kelner, MJ | 2 |
| McMorris, TC | 2 |
| Estes, L | 2 |
| Samson, KM | 1 |
| Bagnell, RD | 1 |
| Taetle, R | 1 |
| Geiger, T | 1 |
| Müller, M | 1 |
| Monia, BP | 1 |
| Fabbro, D | 1 |
| Han, JY | 1 |
| Kim, HK | 1 |
| Choi, BG | 1 |
| Moon, H | 1 |
| Hong, YS | 1 |
| Lee, KS | 1 |
| Ciccone, AM | 1 |
| Ruvolo, G | 1 |
| Coloni, GF | 1 |
| Bureau, G | 1 |
| Baumöhl, J | 2 |
| van Cutsem, O | 1 |
| Recloux, P | 1 |
| Zacharias, C | 2 |
| Klastersky, J | 3 |
| Naoe, Y | 2 |
| Kawamura, I | 2 |
| Inami, M | 2 |
| Matsumoto, S | 2 |
| Nishigaki, F | 2 |
| Tsujimoto, S | 2 |
| Manda, T | 2 |
| Shimomura, K | 2 |
| Takagaki, S | 1 |
| Fujiwara, T | 1 |
| Koh, Y | 1 |
| Suzuki, T | 2 |
| Fukumoto, H | 1 |
| de Boer, RH | 1 |
| Pastorino, U | 1 |
| Ramage, F | 1 |
| Goldstraw, P | 1 |
| Oyama, K | 1 |
| Taniguchi, K | 1 |
| Bando, E | 1 |
| Fujita, H | 2 |
| Nio, Y | 1 |
| Nagami, H | 1 |
| Tamura, K | 3 |
| Tsubono, M | 1 |
| Nio, M | 1 |
| Kawabata, K | 1 |
| Hayashi, H | 2 |
| Shiraishi, T | 1 |
| Imai, S | 1 |
| Tsuchitani, T | 1 |
| Mizuta, J | 1 |
| Nakagawa, M | 3 |
| Fukumoto, M | 1 |
| Wada, H | 1 |
| Miyahara, R | 1 |
| Tanaka, F | 1 |
| Hitomi, S | 1 |
| Ohtani, Y | 1 |
| Ishikawa, H | 1 |
| Aihara, S | 1 |
| Kanazawa, H | 1 |
| Hiki, Y | 2 |
| Kakita, A | 1 |
| Inoue, S | 1 |
| Ichimura, H | 1 |
| Yang, CT | 1 |
| Chang, WJ | 1 |
| Liaw, CC | 1 |
| Tsao, TC | 1 |
| Woodroffe, CM | 2 |
| Chetiyawardana, AD | 2 |
| Joshi, R | 2 |
| Cook, JE | 1 |
| Trask, C | 1 |
| Bessell, E | 1 |
| Connolly, CK | 1 |
| Tobias, J | 1 |
| Souhami, RL | 2 |
| Miyashita, M | 1 |
| Ng, KK | 1 |
| Ginsberg, RJ | 1 |
| Miller, VA | 1 |
| Grant, SC | 1 |
| Bains, M | 1 |
| Rusch, V | 1 |
| Rosenzweig, KE | 1 |
| Ricci, S | 1 |
| Ceribelli, A | 1 |
| Bianco, R | 1 |
| Marangolo, M | 1 |
| Sassi, M | 1 |
| Barni, S | 1 |
| Ravaioli, A | 1 |
| Adamo, V | 1 |
| Cruciani, G | 1 |
| Masotti, A | 1 |
| Gozzelino, F | 1 |
| Nishikawa, H | 2 |
| Katagami, N | 1 |
| Sasaki, M | 1 |
| Kuwabara, Y | 1 |
| Ichiya, Y | 1 |
| Soeda, H | 1 |
| Sugio, K | 1 |
| Masuda, K | 1 |
| Javier Sánchez, J | 1 |
| Padilla, J | 1 |
| Cantó, A | 1 |
| Roig, J | 1 |
| Kim, MS | 1 |
| Choe, DH | 1 |
| Cho, KJ | 1 |
| Toyoizumi, T | 1 |
| Mick, R | 1 |
| Abbas, AE | 1 |
| Kang, EH | 1 |
| Kaiser, LR | 2 |
| Molnar-Kimber, KL | 1 |
| Seto, M | 1 |
| Ono, K | 1 |
| Kurano, R | 1 |
| Hosomi, Y | 2 |
| Mito, K | 1 |
| Uramoto, H | 1 |
| Moriyama, E | 1 |
| Tanaka, K | 2 |
| Hojo, F | 2 |
| Kakinuma, R | 2 |
| Ali, MA | 1 |
| Kraut, MJ | 1 |
| Valdivieso, M | 1 |
| Wozniak, AJ | 1 |
| Cummings, G | 1 |
| Kalemkerian, GP | 1 |
| Bini, A | 1 |
| Zompatori, M | 1 |
| Ansaloni, L | 1 |
| Grazia, M | 1 |
| Stella, F | 1 |
| Bazzocchi, R | 1 |
| Yoshimasu, T | 1 |
| Oura, S | 1 |
| Maebeya, S | 1 |
| Tanino, H | 1 |
| Bessho, T | 1 |
| Arimoto, J | 1 |
| Sakurai, T | 1 |
| Matsuyama, K | 1 |
| Furukawa, T | 2 |
| Yano, T | 1 |
| Suzuma, T | 1 |
| Hirai, I | 1 |
| Wexler, EJ | 1 |
| Gravallese, EM | 1 |
| Czerniak, PM | 1 |
| Devenny, JJ | 1 |
| Longtine, J | 1 |
| Wong, MK | 1 |
| Slee, AM | 1 |
| Kerr, JS | 1 |
| Saini, A | 1 |
| Webb, A | 1 |
| Gregory, K | 1 |
| Mendes, R | 1 |
| Ryan, C | 1 |
| Bromelow, KV | 1 |
| Palmer, RD | 1 |
| Tuckwell, N | 1 |
| Kennard, DA | 1 |
| Souberbielle, BE | 1 |
| Sandler, A | 1 |
| Eifel, PJ | 1 |
| Alexopoulos, CG | 1 |
| Schmerber, J | 1 |
| Florin, MC | 1 |
| Sayit, E | 1 |
| Aktoğu, S | 1 |
| Ertay, T | 1 |
| Capa, G | 1 |
| Erkmen, G | 1 |
| Ozbilek, E | 1 |
| Büyükşirin, M | 1 |
| Durak, H | 1 |
| Itakura, K | 1 |
| Mouri, T | 1 |
| Arizumi, T | 1 |
| Suzuki, J | 1 |
| Chida, H | 1 |
| Kanda, A | 1 |
| Yanai, M | 1 |
| Hirai, H | 1 |
| Katayama, A | 1 |
| Mafune, K | 1 |
| Makuuchi, M | 1 |
| Aoki, H | 1 |
| Kuwahara, K | 1 |
| Minegishi, Y | 1 |
| Okano, T | 1 |
| Hayashihara, K | 1 |
| Watanabe, S | 1 |
| Nemoto, E | 1 |
| Fukai, S | 1 |
| Yanai, N | 2 |
| Gérinière, L | 1 |
| Doddoli, C | 1 |
| Reynaud-Gaubert, M | 1 |
| Giudicelli, R | 1 |
| Papazian, L | 1 |
| Fuentes, P | 1 |
| Talbot, DC | 1 |
| Nicolson, MC | 1 |
| Mansi, JL | 1 |
| Hickish, TF | 1 |
| Müller, H | 2 |
| Johnston, MR | 1 |
| Mullen, JB | 1 |
| Pagura, ME | 1 |
| Howard, RB | 1 |
| Arnau Obrer, A | 2 |
| Martín Díaz, E | 2 |
| Pérez Alonso, D | 2 |
| Regueiro Mira, F | 2 |
| Cervera Juan, A | 2 |
| Granell Gil, M | 2 |
| Roch Pendería, S | 1 |
| Cantó Armengod, A | 2 |
| Bahl, A | 1 |
| Falk, S | 1 |
| Ghisdal, L | 1 |
| Branle, F | 1 |
| Vallot, F | 1 |
| Lemaitre, F | 1 |
| Steels, E | 1 |
| Burniat, A | 1 |
| Mascaux, C | 1 |
| Tsavaris, N | 1 |
| Kosmas, CH | 1 |
| Vadiaka, M | 1 |
| Kontos, A | 1 |
| Katsorida, M | 1 |
| Dimitrakopoulos, A | 1 |
| Zerai, A | 1 |
| Koufos, CH | 1 |
| Simamura, E | 1 |
| Hirai, KI | 1 |
| Shimada, H | 2 |
| Koyama, J | 1 |
| Cañizares Carretero, M | 1 |
| Roch Tejerina, S | 1 |
| Yano, S | 1 |
| Uoshima, N | 1 |
| Yoshioka, K | 1 |
| Tegoshi, H | 1 |
| Wada, S | 1 |
| Satake, N | 1 |
| Kasamatsu, Y | 2 |
| Yokoho, S | 1 |
| Rixe, O | 1 |
| Urban, T | 1 |
| Baud, M | 1 |
| Collon, T | 1 |
| Le Guen, Y | 1 |
| Febvre, M | 1 |
| Touboul, E | 1 |
| Jelić, S | 1 |
| Mitrović, L | 1 |
| Radosavljević, D | 1 |
| Elezar, E | 1 |
| Babović, N | 1 |
| Kovcin, V | 1 |
| Tomasević, Z | 1 |
| Kovacević, S | 1 |
| Gavrilović, D | 1 |
| Radulović, S | 1 |
| Ike, H | 1 |
| Sadahiro, S | 1 |
| Oya, K | 1 |
| Otani, Y | 1 |
| Yamaguchi, S | 1 |
| Mitomi, T | 1 |
| Erkisi, M | 1 |
| Erkurt, E | 1 |
| Zeren, H | 1 |
| Tunali, C | 1 |
| Kocabas, A | 1 |
| Burgut, R | 1 |
| Chevret, S | 1 |
| Lemarié, E | 1 |
| Gouva, S | 1 |
| Bréchot, JM | 1 |
| Terrioux, P | 1 |
| Foucher, P | 1 |
| Monchâtre, M | 1 |
| Coëtmeur, D | 1 |
| Leclerc, P | 1 |
| Blanchon, F | 1 |
| Rodier, JM | 1 |
| Thiberville, L | 1 |
| Villeneuve, A | 1 |
| Lu, S | 1 |
| Liao, M | 1 |
| Lin, Z | 1 |
| Zhang, X | 1 |
| Sun, Y | 3 |
| Feng, F | 1 |
| Gregory, RK | 1 |
| Kunikane, H | 1 |
| Ikegami, H | 1 |
| Kishimoto, S | 1 |
| Tokura, H | 1 |
| Ikeda, T | 2 |
| Kitajima, M | 2 |
| Furue, H | 1 |
| Ikeda, M | 1 |
| Fujii, T | 1 |
| Rikimaru, T | 1 |
| Chu, DT | 1 |
| Zhang, XR | 1 |
| Li, JL | 1 |
| Qu, FL | 1 |
| Hosoe, S | 1 |
| Okishio, K | 1 |
| Sunami, T | 1 |
| Mitsuoka, S | 1 |
| Gagnadoux, F | 1 |
| Capron, F | 1 |
| Rojas, RJ | 1 |
| Trani, NA | 1 |
| Motomiya, M | 1 |
| Hasegawa, K | 1 |
| Kuriyama, T | 1 |
| Hirabayashi, M | 1 |
| Yoshida, H | 1 |
| Kawakami, K | 1 |
| Mishima, M | 1 |
| Kuno, K | 1 |
| Kuo, SH | 1 |
| Feldman, ER | 1 |
| Eagan, RT | 4 |
| Schaid, DJ | 1 |
| Zamora, P | 1 |
| Garcia de Paredes, ML | 1 |
| Chacon, JI | 1 |
| Malkinson, AM | 1 |
| Forrest, GL | 1 |
| Gazdar, AF | 1 |
| Oie, HK | 1 |
| Chan, DC | 1 |
| Mabry, M | 1 |
| Dykes, DJ | 1 |
| Harrison, SD | 1 |
| Athanassiades, P | 1 |
| Athanassiades, H | 1 |
| Psychogiou, E | 1 |
| Kokolakis, N | 1 |
| Giannioti, E | 1 |
| Komada, H | 1 |
| Yamamura, M | 1 |
| Kawaguchi, Y | 1 |
| Kwon, M | 1 |
| Uetsuji, S | 1 |
| Kamiyama, Y | 1 |
| Nakanishi, Y | 1 |
| Ikeda, K | 1 |
| Harima, K | 1 |
| Otaki, S | 1 |
| Kaneko, H | 1 |
| Fukuma, E | 1 |
| Yamakawa, T | 1 |
| Kubota, T | 1 |
| Yamamoto, T | 1 |
| Takahara, T | 1 |
| Ishibiki, K | 1 |
| Shida, Y | 1 |
| Nakatsubo, H | 1 |
| Barone, C | 1 |
| Astone, A | 1 |
| Cassano, A | 1 |
| Noviello, MR | 1 |
| Fontana, T | 1 |
| Grieco, A | 1 |
| Thompson, CC | 1 |
| Bailey, MK | 1 |
| Conroy, JM | 1 |
| Bromley, HR | 1 |
| Miya, T | 2 |
| Karato, A | 1 |
| Lee, YK | 1 |
| Shin, DM | 1 |
| Hashimoto, T | 1 |
| Araki, H | 1 |
| Yasui, K | 1 |
| Kodama, M | 1 |
| Stockler, M | 1 |
| Raghavan, D | 1 |
| McCaughan, BC | 1 |
| Grygiel, J | 1 |
| McNeil, E | 1 |
| Gianoutsos, P | 1 |
| Lee, JH | 1 |
| Jirillo, A | 2 |
| Pavanato, G | 1 |
| Lonardi, F | 2 |
| Bonciarelli, G | 2 |
| Balli, M | 2 |
| Veeder, MH | 1 |
| Jett, JR | 4 |
| Su, JQ | 1 |
| Mailliard, JA | 1 |
| Foley, JF | 1 |
| Dalton, RJ | 2 |
| Etzell, PS | 1 |
| Marschke, RF | 2 |
| Kardinal, CG | 1 |
| Maksymiuk, AW | 1 |
| Fujii, S | 2 |
| Lenz, C | 1 |
| Uemura, M | 1 |
| Sawada, M | 2 |
| Takemura, S | 1 |
| Sugino, S | 1 |
| Kondou, M | 1 |
| Matsuda, H | 1 |
| Tong, CN | 1 |
| Kubo, M | 1 |
| Konishi, M | 1 |
| Mikasa, K | 1 |
| Maeda, K | 1 |
| Tomoda, K | 1 |
| Konoike, Y | 1 |
| Sawaki, M | 1 |
| Narita, N | 1 |
| Ueda, E | 1 |
| Sako, M | 1 |
| Sella, A | 1 |
| Fitz, K | 1 |
| Dexeus, FH | 1 |
| Amato, R | 1 |
| Kilbourn, R | 1 |
| Wallace, S | 1 |
| Watanabe, M | 1 |
| Kawamura, M | 2 |
| Kikuchi, K | 2 |
| Ishihara, T | 1 |
| Mouri, M | 1 |
| Arika, T | 1 |
| Amemiya, K | 1 |
| Içli, F | 1 |
| Günel, N | 1 |
| Dinçol, D | 1 |
| Karaoğuz, H | 1 |
| Demirkazik, A | 1 |
| Iberti, V | 1 |
| Donadio, M | 2 |
| Testore, F | 2 |
| Niimi, T | 1 |
| Kajita, M | 1 |
| Ohta, M | 4 |
| Hara, N | 4 |
| Iacobelli, S | 1 |
| Gentile, M | 1 |
| Garufi, C | 1 |
| Palmieri, G | 1 |
| Gatzemeier, U | 4 |
| Heckmayr, M | 2 |
| Hossfeld, DK | 3 |
| Kaukel, E | 4 |
| Koschel, G | 4 |
| Neuhauss, R | 3 |
| Sawada, Y | 1 |
| Iwamoto, S | 1 |
| Yurino, N | 1 |
| Murai, N | 1 |
| Okuno, F | 1 |
| Kotake, H | 1 |
| Mashiba, H | 1 |
| Motohiro, A | 1 |
| Kuda, T | 1 |
| Aso, H | 1 |
| Tsuchiya, Y | 1 |
| Kobayakawa, K | 1 |
| Kawahara, T | 1 |
| Gomm, SA | 1 |
| Cuthbert, A | 1 |
| Chang, J | 1 |
| Burmester, H | 1 |
| Hall, P | 1 |
| Carroll, KB | 1 |
| Kurane, S | 1 |
| Kobayashi, K | 1 |
| Nukariya, N | 1 |
| Morikawa, T | 1 |
| Hino, M | 2 |
| Sibuya, M | 1 |
| Higano, CS | 1 |
| Crowley, J | 1 |
| Livingston, RB | 2 |
| Goodwin, JW | 1 |
| Barlogie, B | 1 |
| Stuckey, WJ | 1 |
| Häussinger, K | 2 |
| Martinelli, G | 1 |
| von Pawel, J | 2 |
| Kojima, A | 2 |
| Tanaka, N | 2 |
| Kuramitsu, T | 1 |
| Uchisako, H | 1 |
| Nakaki, H | 1 |
| Suda, H | 3 |
| Nakamura, H | 1 |
| Bilfinger, TV | 1 |
| Hartman, AR | 1 |
| Ichikawa, Y | 2 |
| Kanda, T | 2 |
| Shima, K | 2 |
| Hokama, M | 2 |
| Suzuki, K | 2 |
| Tanaka, J | 1 |
| Kamata, N | 1 |
| Kosuda, S | 1 |
| Sakai, T | 1 |
| Kaseda, S | 1 |
| Bouillet, T | 1 |
| Lepage, E | 1 |
| Gisselbrecht, C | 1 |
| Boiron, M | 1 |
| Sudo, Y | 1 |
| Asami, N | 1 |
| Takahashi, T | 1 |
| Yamaguchi, T | 1 |
| Kitamura, K | 1 |
| Noguchi, A | 1 |
| Honda, M | 1 |
| Otsuji, E | 1 |
| Shimizu, J | 2 |
| Murakami, S | 1 |
| Tsubota, M | 1 |
| Iwa, T | 1 |
| Kitagawa, M | 1 |
| Mizukami, Y | 1 |
| Nonomura, A | 1 |
| Matsubara, F | 1 |
| Currie, DC | 1 |
| Miles, DW | 1 |
| Drake, JS | 1 |
| Rudd, R | 1 |
| Earl, HM | 1 |
| Tobias, JS | 1 |
| Abad-Esteve, A | 1 |
| Fernandez, C | 1 |
| Ribelles, N | 1 |
| Culubret, M | 1 |
| Meacci, ML | 2 |
| Buzzi, F | 2 |
| Fornari, G | 2 |
| Santi, E | 1 |
| Ballatori, E | 2 |
| Koga, K | 1 |
| Minoda, S | 1 |
| Watanabe, A | 2 |
| Horio, Y | 1 |
| Shibagaki, T | 1 |
| Iwahara, T | 1 |
| Laumen, R | 1 |
| Jungbluth, H | 1 |
| Otto, M | 1 |
| Krieger, H | 1 |
| Jones, WB | 1 |
| Wagner-Reiss, KM | 1 |
| Lewis, JL | 1 |
| Hayashi, Y | 1 |
| Kato, M | 2 |
| Matsuura, T | 1 |
| Ito, G | 1 |
| Takeuchi, T | 1 |
| Gandara, DR | 1 |
| Perez, EA | 1 |
| Wold, H | 1 |
| Caggiano, V | 1 |
| Malec, M | 1 |
| Ahn, DK | 1 |
| Meyers, F | 1 |
| Carlson, RW | 1 |
| Huang, DP | 1 |
| Fujita, J | 3 |
| Wright, JC | 1 |
| Kori, Y | 1 |
| Koyama, M | 1 |
| Honda, Y | 1 |
| Kawata, Y | 1 |
| Arai, S | 1 |
| Ito, T | 2 |
| Nakabayashi, T | 1 |
| Yasuda, S | 1 |
| Miyamoto, H | 2 |
| Abe, S | 2 |
| Ohosaki, Y | 1 |
| Sagawa, M | 3 |
| Nagamoto, N | 3 |
| Usuda, K | 3 |
| Ohta, S | 3 |
| Kanma, K | 1 |
| Imai, T | 3 |
| Saito, Y | 1 |
| Inaoka, M | 1 |
| Kusajima, K | 1 |
| Kawashima, T | 1 |
| Iwata, M | 1 |
| Morikawa, M | 1 |
| Mishina, H | 1 |
| Komatsu, S | 1 |
| Inoue, F | 1 |
| Takeda, I | 1 |
| Miyake, M | 2 |
| Mimura, H | 1 |
| Fujiwara, K | 1 |
| Jyojya, I | 1 |
| Ono, T | 1 |
| Demicheli, R | 1 |
| Lele, SB | 1 |
| Piver, MS | 1 |
| Trush, MA | 1 |
| Thompson, DC | 1 |
| Hardy, JR | 1 |
| Noble, T | 1 |
| Keizer, HG | 1 |
| De Leeuw, SJ | 1 |
| Van Rijn, J | 1 |
| Pinedo, HM | 1 |
| Joenje, H | 1 |
| Thomas, G | 1 |
| Dembo, A | 1 |
| DePetrillo, A | 1 |
| Pringle, J | 1 |
| Ackerman, I | 1 |
| Bryson, P | 1 |
| Balogh, J | 1 |
| Osborne, R | 1 |
| Rosen, B | 1 |
| Fyles, A | 1 |
| Johansson, M | 1 |
| Orndal, C | 1 |
| Nagao, K | 1 |
| Baba, K | 1 |
| Nishimura, R | 1 |
| Matsuoka, Y | 1 |
| Ueno, Y | 1 |
| Morinaga, H | 1 |
| Nagase, H | 1 |
| Kawano, H | 1 |
| Setoguchi, J | 1 |
| Onodera, H | 1 |
| Sigeta, M | 1 |
| Nakai, M | 1 |
| Kanatsuna, T | 1 |
| Kondoh, M | 1 |
| Hotta, T | 1 |
| Fukuhara, H | 1 |
| Oomura, M | 1 |
| Hüttner, J | 1 |
| Wiener, N | 1 |
| Quadt, C | 1 |
| Dallüge, KH | 1 |
| Grunau, H | 1 |
| Tanneberger, S | 1 |
| Merkle, K | 1 |
| Viallet, J | 1 |
| Propert, KJ | 1 |
| Ware, JH | 1 |
| Zimmer, B | 1 |
| Perry, MC | 1 |
| Hirsh, V | 1 |
| Skarin, A | 1 |
| Kopel, S | 1 |
| Comis, RL | 1 |
| Houya, I | 1 |
| Kimura, I | 2 |
| Nagata, M | 1 |
| Kiuchi, H | 1 |
| Sakamoto, Y | 1 |
| Dohi, Y | 1 |
| Kaneko, K | 1 |
| Kawano, K | 1 |
| Tada, I | 1 |
| Nakashima, K | 1 |
| Mitarai, Y | 1 |
| Kim, YI | 1 |
| Minato, K | 2 |
| Kamei, T | 1 |
| Mukai, J | 2 |
| Kunishige, E | 1 |
| Fukuta, K | 1 |
| Tani, K | 1 |
| Sugiura, T | 1 |
| Inoue, K | 1 |
| Horikoshi, N | 1 |
| Mukaiyama, T | 1 |
| Treat, J | 1 |
| Falchuk, SC | 1 |
| Tremblay, C | 1 |
| Spielman, M | 1 |
| Woolley, PV | 1 |
| Rouesse, J | 1 |
| Sevin, D | 1 |
| Le Chevalier, T | 1 |
| Kimura, M | 1 |
| Komuro, Y | 1 |
| Ohnishi, M | 1 |
| Saitoh, A | 1 |
| Morohashi, Y | 1 |
| Zhou, JC | 1 |
| Feng, FY | 1 |
| Wang, QL | 1 |
| Zeng, WY | 1 |
| Liu, YY | 1 |
| Bagatella, M | 1 |
| Bonardi, GM | 1 |
| Ferrati, P | 1 |
| Ciuffreda, L | 1 |
| Calciati, A | 1 |
| Frytak, S | 3 |
| Richardson, RL | 3 |
| Creagan, ET | 3 |
| Therneau, TM | 1 |
| Coles, DT | 2 |
| Palmer, KC | 1 |
| Mooradian, DL | 1 |
| Diglio, CA | 1 |
| Rosman, M | 1 |
| Mira, JG | 1 |
| Taylor, SL | 1 |
| Stephens, RL | 1 |
| Chen, T | 1 |
| Cooley, TP | 1 |
| Finkel, HE | 1 |
| Wright, J | 1 |
| Hesketh, AM | 1 |
| Ishino, Y | 1 |
| Terashima, H | 1 |
| Nakata, H | 1 |
| Yoshimatsu, H | 1 |
| Sanefuji, H | 1 |
| Santi, F | 1 |
| Luccioli, L | 1 |
| Moore, M | 1 |
| Klein, E | 1 |
| Iida, S | 1 |
| Yamada, T | 1 |
| Kimoto, H | 1 |
| Tsunamura, Y | 1 |
| Ichihashi, T | 1 |
| Hashizume, Y | 1 |
| Konno, T | 1 |
| Yano, H | 1 |
| Hayashibe, A | 1 |
| Honda, R | 1 |
| Kitaya, T | 1 |
| Matsuyama, T | 1 |
| Nabeshima, K | 1 |
| Iwahashi, N | 1 |
| Fujii, J | 1 |
| Hada, T | 1 |
| Higashino, K | 1 |
| Koike, S | 1 |
| Kawakami, T | 1 |
| Naito, M | 1 |
| Moriwaki, S | 1 |
| Sadamoto, M | 1 |
| Kanzawa, F | 1 |
| Matsushima, Y | 1 |
| Petursson, SR | 1 |
| Radenbach, D | 1 |
| Zschaber, R | 1 |
| Zatz, LM | 1 |
| Wasserstein, P | 1 |
| Cox, RS | 1 |
| Kushlan, PD | 1 |
| Porzig, KJ | 1 |
| Nakano, H | 1 |
| Kurihara, M | 1 |
| Saito, R | 1 |
| Tsuchiya, S | 1 |
| Takehara, K | 1 |
| Saruya, T | 1 |
| Kuwabara, H | 1 |
| Fueki, R | 1 |
| Homma, T | 1 |
| Fukuda, Y | 1 |
| Nakata, M | 1 |
| Noguchi, Y | 1 |
| Yoshida, S | 1 |
| Hohjo, F | 1 |
| Hashimoto, Y | 2 |
| Mutsuura, S | 2 |
| Yamasaki, K | 1 |
| Tada, T | 2 |
| Yamashita, T | 2 |
| Ohnoshi, T | 2 |
| Hain, E | 1 |
| Arraztoa, J | 1 |
| Orlandi, L | 1 |
| Rodríguez, R | 1 |
| Vogel, C | 1 |
| Ramírez, G | 1 |
| Sakuma, T | 1 |
| Takahashi, S | 2 |
| Satoh, M | 2 |
| Kamma, K | 2 |
| Shaw, MT | 1 |
| Shaw, MK | 1 |
| Finkelstein, DM | 3 |
| Cassileth, BR | 1 |
| Bonomi, PD | 1 |
| Ruckdeschel, JC | 3 |
| Ezdinli, EZ | 1 |
| Wolter, JM | 1 |
| Cohen, AM | 1 |
| Schaeffer, N | 1 |
| Higgins, J | 1 |
| Pandya, KJ | 3 |
| Chang, AY | 3 |
| Qazi, R | 1 |
| Rubins, J | 1 |
| Asbury, R | 1 |
| Nichols, WC | 1 |
| Inoue, I | 1 |
| Kuebler, JP | 2 |
| Israel, RH | 1 |
| Marshall, BC | 1 |
| Tormey, DC | 2 |
| Ekholm, SE | 1 |
| Dahlbäck, O | 1 |
| Einhorn, LH | 1 |
| Loehrer, PJ | 1 |
| Williams, SD | 1 |
| Meyers, S | 1 |
| Gabrys, T | 1 |
| Nattan, SR | 1 |
| Woodburn, R | 1 |
| Drasga, R | 1 |
| Songer, J | 1 |
| Fisher, W | 1 |
| Ishizeki, S | 1 |
| Ohtsuka, M | 1 |
| Irinoda, K | 1 |
| Kukita, K | 1 |
| Nagaoka, K | 1 |
| Nakashima, T | 1 |
| Itaya, T | 1 |
| Yamagiwa, S | 1 |
| Okada, F | 1 |
| Oikawa, T | 1 |
| Kuzumaki, N | 1 |
| Takeichi, N | 1 |
| Hosokawa, M | 1 |
| So, SY | 2 |
| Kung, TM | 1 |
| Sham, MK | 1 |
| Takahashi, A | 1 |
| Takagi, M | 1 |
| Hishida, H | 1 |
| Saji, E | 1 |
| Takagi, N | 1 |
| Amano, H | 1 |
| Ogura, Y | 1 |
| Ibe, Y | 1 |
| Naito, S | 1 |
| Fujieda, K | 1 |
| Okubo, S | 1 |
| Morinari, H | 1 |
| Yusa, T | 1 |
| Sekine, Y | 1 |
| Masuda, H | 1 |
| Takagi, K | 1 |
| Tanaka, S | 1 |
| Tsubura, E | 1 |
| Wu, YM | 1 |
| Wang, ZT | 1 |
| Yew, WW | 1 |
| Chan, SL | 1 |
| Kwan, SY | 1 |
| Ettinger, DS | 2 |
| Creech, RH | 1 |
| Mason, BA | 1 |
| Vogl, S | 1 |
| Wertheim, MS | 1 |
| Kelsen, DP | 1 |
| O'Connell, JP | 1 |
| Burke, MT | 1 |
| Fiore, JJ | 1 |
| Cibas, IR | 1 |
| Miller, TP | 1 |
| Vance, RB | 1 |
| Ahmann, FR | 1 |
| Rodney, SR | 1 |
| Shepherd, FA | 1 |
| Evans, WK | 1 |
| Burkes, R | 1 |
| Paul, K | 1 |
| DeBoer, G | 1 |
| Krook, JE | 1 |
| Fleming, TR | 1 |
| Cullinan, SA | 1 |
| Windschitl, HE | 1 |
| Everson, LK | 1 |
| Brunk, FS | 1 |
| Laurie, JA | 1 |
| Luedke, D | 1 |
| McLaughlin, TT | 1 |
| Daughaday, C | 1 |
| Luedke, S | 1 |
| Harrison, B | 1 |
| Reed, G | 1 |
| Martello, O | 1 |
| Kimata, M | 1 |
| Futami, H | 2 |
| Ishikawa, S | 1 |
| Hayashi, K | 1 |
| Ree, T | 1 |
| Saotome, K | 1 |
| Iriki, A | 1 |
| Kimura, S | 1 |
| Hirata, M | 1 |
| Nishiyama, Y | 1 |
| Yu, DY | 1 |
| Gatanaga, T | 1 |
| Yamazaki, M | 1 |
| Mizuno, D | 1 |
| Borden, EC | 1 |
| Davis, TE | 1 |
| Trump, DL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Randomized Trial of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer[NCT00201747] | Phase 2 | 80 participants (Actual) | Interventional | 2001-09-30 | Completed | ||
| Pembrolizumab + Platinum Doublets Without Radiation for Patients With PD-L1 ≥50% Locally Advanced Non-small Cell Lung Cancer: a Multicenter Prospective Single Arm Phase II Study[NCT04153734] | Phase 2 | 21 participants (Anticipated) | Interventional | 2019-12-01 | Not yet recruiting | ||
| A Prospective Phase Ⅱ Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer[NCT02573506] | Phase 2 | 99 participants (Actual) | Interventional | 2015-08-31 | Completed | ||
| Split-course Thoracic Radiotherapy Combined With Nab-paclitaxel Plus Nedaplatin for Local Advanced NSCLC With Impaired Baseline Pulmonary Function[NCT04212052] | Phase 2 | 71 participants (Anticipated) | Interventional | 2019-12-01 | Active, not recruiting | ||
| A Phase II,Randomized Controlled Clinical Trial of Staged Thoracic Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin Twice a Week for Locally Advanced NSCLC[NCT04524299] | Phase 2 | 160 participants (Anticipated) | Interventional | 2020-06-01 | Recruiting | ||
| Hypofractionated Radiotherapy Followed by Hypofractionated Boost With Weekly Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: A Prospective, Single Arm Phase II Study[NCT03900117] | Phase 2 | 77 participants (Actual) | Interventional | 2019-03-01 | Completed | ||
| Phase III Trial Comparing 2 Chemotherapy Schedules (Preoperative vs Pre and Postoperative) in Stage I and II NSCLC[NCT00198354] | Phase 3 | 530 participants (Actual) | Interventional | 2001-05-31 | Completed | ||
| Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable Non-Small-Cell Lung Cancer.[NCT02259621] | Phase 2 | 45 participants (Anticipated) | Interventional | 2014-09-30 | Active, not recruiting | ||
| Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)[NCT02734069] | 132 participants (Anticipated) | Observational | 2016-02-29 | Recruiting | |||
| A Phase II, Randomised Study of Nivolumab as Consolidation Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent C[NCT04085250] | Phase 2 | 264 participants (Actual) | Interventional | 2019-11-28 | Active, not recruiting | ||
| Fraction Dose Escalation of Hypofractionated Radiotherapy With Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non-small Cell Lung Cancer: a Phase 1 Study[NCT04951063] | Phase 1 | 18 participants (Actual) | Interventional | 2021-06-01 | Completed | ||
| A Phase II Trial of 3 Dimensional Proton Radiotherapy With Concomitant Chemotherapy for Patients With Initially Unresectable Stage III Non-Small Cell Lung Cancer[NCT00881712] | 15 participants (Actual) | Interventional | 2009-06-30 | Terminated (stopped due to projected enrollment rate not feasible) | |||
| A Prospective, Randomized, Phase Ⅱ Study of Split-course Chemoradiotherapy For Locoregional Recurrence Of Non-small Cell Lung Cancer After Surgical Resection[NCT03006575] | Phase 2 | 57 participants (Anticipated) | Interventional | 2015-08-31 | Recruiting | ||
| A Remotely Supervised Exercise Program for Lung Cancer Patients Undergoing Chemoradiation[NCT03500393] | 4 participants (Actual) | Interventional | 2018-06-22 | Terminated (stopped due to feasibility of study recruitment) | |||
| A Prospective Randomized Phase Ⅱ Study of Nimotuzumab Combined With Chemoradiotherapy for Unresectable, Locally Advanced Squamous Cell Lung Cancer[NCT02577341] | Phase 2 | 122 participants (Actual) | Interventional | 2015-08-31 | Completed | ||
| A Phase II Study of Thymopeptide a1 During Split-course Chemoradiotherapy to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer[NCT03659578] | Phase 2 | 69 participants (Actual) | Interventional | 2018-08-09 | Completed | ||
| Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer Using Hypofractionated Technique.[NCT04275687] | Phase 2 | 35 participants (Anticipated) | Interventional | 2020-03-01 | Recruiting | ||
| Double Lung Transplant REgistry Aimed for Lung-limited Malignancies (DREAM) - a Prospective Observational Registry Study for Patients Undergoing Lung Transplantation for Medically Refractory Cancers Confined to the Lungs[NCT05671887] | 125 participants (Anticipated) | Observational [Patient Registry] | 2022-11-16 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00881712)
Timeframe: Six months after end of radiation therapy
| Intervention | participants (Number) |
|---|---|
| PET Positive Nodal Disease Measuring 15 mm or Greater | 1 |
(NCT00881712)
Timeframe: Five years following radiation treatment
| Intervention | percentage of patients (Number) |
|---|---|
| PET Positive Nodal Disease Measuring 15 mm or Greater | 69 |
"Disease control rate is defined as Complete Response (CR) + Partial Response (PR) + Stable Disease (SD). As per RECIST version 1.1, Complete Response (CR): Disappearance of all target lesions, Partial Response (PR): At least a 30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum diameters, Stable Disease (SD): Neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD, taking as reference the smallest sum diameters while on study.), as accurate." (NCT00881712)
Timeframe: Following treatment every 6 months for 2 years, then annually for 4 years.
| Intervention | percentage of participants (Number) |
|---|---|
| PET Positive Nodal Disease Measuring 15 mm or Greater | 69 |
33 reviews available for mitomycin and Cancer of Lung
| Article | Year |
|---|---|
Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Doxorubicin; Drug Carriers; Humans; Lung Neoplasms; | 2018 |
Are RAS mutations predictive markers of resistance to standard chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat | 2009 |
[Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2003 |
[Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoth | 2005 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm | 1983 |
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1995 |
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1995 |
Mitomycin C.
Topics: Carcinoma, Non-Small-Cell Lung; Drug Design; Humans; Lung Neoplasms; Mitomycin; NAD(P)H Dehydrogenas | 1993 |
Experience with mitomycin in the treatment of non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Th | 1993 |
The case for mitomycin in non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Hum | 1993 |
The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat | 1996 |
[gamma-Glutamylcysteine synthetase and chemosensitivity].
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Neopla | 1997 |
[Adjuvant chemotherapy of lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cispl | 1987 |
[Combination chemotherapy in the treatment of inoperable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cispla | 1997 |
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phyto | 1998 |
Drug resistance in lung cancer.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; C | 1999 |
Bilateral recurrent pneumothorax complicating chemotherapy for pulmonary metastatic breast ductal carcinoma: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cycloph | 2000 |
Chemotherapy in metastatic non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell | 2000 |
Chemoradiation for carcinoma of the cervix: advances and opportunities.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, A | 2000 |
Adrenalectomy for solitary adrenal metastasis from colorectal carcinoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2000 |
[Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineopl | 2000 |
The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature.
Topics: Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Humans; Lung | 2001 |
[Intra-arterial infusion chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Drug Admin | 2002 |
The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical | 2002 |
[ Early anti-cancer drugs].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 2002 |
Non-small-cell lung cancer (NSCLC): chemotherapy in advanced disease. Our experience in ten years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical | 1992 |
[A case of secondary myelodysplastic syndrome following chemotherapy for lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitio | 1992 |
[Dose intensity chemotherapy in lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel | 1990 |
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
Update in cancer chemotherapy, Part III: Lung cancer, Part 1.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bleomycin; Carcinoma; C | 1985 |
[5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; | 1989 |
Current chemotherapy of small cell lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combi | 1986 |
Chemotherapy of non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Tolera | 1985 |
164 trials available for mitomycin and Cancer of Lung
| Article | Year |
|---|---|
Bronchial or Pulmonary Artery Chemoembolization for Unresectable and Unablatable Lung Metastases: A Phase I Clinical Trial.
Topics: Aged; Antibiotics, Antineoplastic; Bronchial Arteries; Chemoembolization, Therapeutic; Ethiodized Oi | 2021 |
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.
Topics: Administration, Inhalation; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; | 2016 |
Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colorectal | 1972 |
A phase II trial of induction chemotherapy followed by continuous hyperfractionated accelerated radiotherapy in locally advanced non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; C | 2009 |
Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carcin | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2010 |
Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, N | 2010 |
Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2011 |
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2012 |
Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino | 2012 |
Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherap | 2012 |
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2002 |
Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cos | 2002 |
Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology G
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; F | 2002 |
[Comparison of effects of three chemotherapy regimens for advanced non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel | 2002 |
[Comparison of NP and MVP regimen in treatment of advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2002 |
[Clinical observation on effect of chemotherapy combined with Chinese medicine in treating advanced tumor patients and on immunologic parameters].
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols | 2001 |
[Influence of combined therapy of guben yiliu III, moxibustion and chemotherapy on immune function and blood coagulation mechanism in patients with mid-late stage malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carboplatin; Cisplatin; Cyclophos | 2002 |
[Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astragalus propinquus; CD4-CD8 Ratio; Cisplatin; Cyc | 2002 |
A phase II study of vinorelbine, mitomycin C and cisplatin chemotherapy for advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2002 |
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; C | 2003 |
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small | 2003 |
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 2004 |
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino | 2004 |
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Bo | 2004 |
[Prospective randomized study of HMVP, MVP, and HVP regimens in treatment of advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell | 2004 |
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antine | 2005 |
Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carc | 2005 |
[Short-term curative effect observation on treatment of tumor by Shengling liquid combined with intervene therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Drug Therapy, Combinati | 2005 |
Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, | 2005 |
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2005 |
Chemotherapy for metastatic NSCLC: current status and future direction.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2005 |
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-F | 2005 |
Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcinoma, Non-Sm | 2005 |
[Clinical trial of chemotherapy identified according to chemosensitivity assay for oral cancer patients with unresectable recurrent lesions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedu | 2006 |
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; H | 2006 |
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino | 2006 |
Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC--a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 2007 |
Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2006 |
Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplati | 2007 |
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; | 2007 |
Efficacy and safety of combination chemotherapy with mitomycin and vinorelbine for the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2008 |
Mitomycin plus vinorelbine salvage chemotherapy in non-small cell lung cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2008 |
Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small | 1984 |
[Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bleomycin; | 1984 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm | 1983 |
[Randomized controlled study of OK-432 in the treatment of cancerous pleurisy].
Topics: Adult; Aged; Biological Products; Clinical Trials as Topic; Female; Humans; Lung Neoplasms; Male; Mi | 1983 |
Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cy | 1984 |
[Clinical evaluation of various antineoplastic agents combined with urokinase--a comparison between urokinase from tissue culture (TCUK) and urine-derived urokinase (UUK)].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Clinical Trials a | 1982 |
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, N | 1993 |
Symptomatic, stage IV, non-small-cell lung cancer (NSCLC): response, toxicity, performance status change and symptom relief in patients treated with cisplatin, vinblastine and mitomycin-C.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1995 |
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1995 |
Preoperative chemotherapy and immunochemotherapy for locally advanced stage IIIA and IIIB non small cell lung cancer. Preliminary results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 1995 |
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Eto | 1995 |
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined | 1995 |
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1995 |
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1995 |
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Eto | 1995 |
Usefulness of the Thai modified functional living index--cancer (T-FLIC) and the Thai modified quality of life index (T-QLI) for advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1995 |
[Clinical and experimental study in treating gastric cancer with replenishing qi and invigorating spleen oral liquid combined with chemotherapy].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Therapy, Combi | 1994 |
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Biotransformation; Bone Marrow Diseases; Carcino | 1995 |
Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncologie Th
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1995 |
[Studies of guben quyu No I combined with chemotherapy in treating cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; CD4-CD8 Ratio; Cyclop | 1994 |
A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinom | 1994 |
[A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1993 |
Mitomycin C etoposide and vinorelbine (MEV II) in the treatment of metastatic stage IV non small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Etoposide; Fem | 1994 |
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1994 |
An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1994 |
A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 1994 |
MICE: a new active combination for non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1993 |
Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1993 |
Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1993 |
Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell | 1993 |
The case for mitomycin in non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Hum | 1993 |
Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-C | 1993 |
A phase II trial of mitomycin C, 5-fluorouracil and radiation therapy in the treatment of unresectable non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1993 |
Cisplatin-mitomycin and vindesine in the treatment of inoperable non-small cell lung cancer groupe français de pneumo-cancérologie (GFPC)
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fem | 1993 |
Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1995 |
Mitomycin C and menadione for the treatment of lung cancer: a phase II trial.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 1995 |
Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carcinoma, Non-Sm | 1996 |
Is the MVP regimen less active than previously described? Results of a phase II study in advanced non-small cell lung cancer.
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Ph | 1996 |
[Effect of timing of granulocyte-colony stimulating factor administration on leukopenia induced by systemic chemotherapy in patients with non-small-cell lung cancer--multi-center randomized crossover study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cross-Ove | 1996 |
Adjuvant chemo-immunotherapy after curative resection of Stage II and IIIA primary lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 1996 |
Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinom | 1996 |
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; | 1996 |
Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, No | 1997 |
[A study on treatment of lung cancer by combined therapy of traditional Chinese medicine and chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino | 1996 |
Efficacy of platinum-based regimens in non-small cell lung cancer. A negative report from the Cuneo Lung Cancer Study Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyc | 1997 |
Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1997 |
A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1997 |
Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; C | 1997 |
A phase III randomized trial of cisplatin plus vindesine versus cisplatin plus vindesine plus mitomycin C versus cisplatin plus vindesine plus ifosfamide for advanced non-small-cell lung cancer.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cel | 1996 |
Advanced non-small cell lung cancer chemotherapy: a randomized trial of two active regimens (MVP and PE).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1997 |
Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Human | 1998 |
[Comparative study on quality of life between weekly and monthly chemotherapy with cisplatin, vindesine and mitomycin C in patients with non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1998 |
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1998 |
Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC).
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 1998 |
Induction chemotherapy for T4 centrally located non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1999 |
Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1999 |
Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion.
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplat | 1999 |
Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 1999 |
[Anti-emetic treatment for patients with non-small cell lung cancer after chemotherapy, usefulness of preventive combination of anti-emetic agents and importance of psychiatric aspect of patients].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell | 1999 |
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase I/II study of vinorelbine, mitomycin, and cisplatin for stage IIIB or IV non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcin | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1999 |
Postoperative adjuvant therapy for stage II non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1999 |
Phase I study of cisplatin and docetaxel plus mitomycin C in patients with metastatic non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doc | 1999 |
A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2000 |
A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Vacci | 2000 |
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-S | 2000 |
Effect of chemotherapy on pulmonary epithelial permeability in lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Gas Analysis; Carcinoma, Non-Small-Cell Lung; | 2000 |
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2001 |
Regional plus systemic chemotherapy: an effective treatment in recurrent non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 2001 |
Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.
Topics: Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2001 |
Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2001 |
[Combination chemotherapy of doxifluridine plus mitomycin C for colorectal lung metastasis--phase II study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms | 2001 |
Anticipated administration of GM-CSF in the treatment of non small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2001 |
Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2002 |
Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Carcinoma, Non-Small-Cell | 2001 |
The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fem | 2001 |
[Clinical usefulness of ondansetron injection in patients receiving cancer chemotherapy].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cis | 2002 |
Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 2002 |
A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; | 2002 |
The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribut | 1992 |
Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Immunity, | 1992 |
Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1992 |
Carboplatin, vinblastine and mitomycin-C in the treatment of non-small cell bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 1992 |
Advanced non-small-cell lung cancer (NSCLC) treated with folinic acid (F), fluorouracil (FU), vincristine (O), and mitomycin-C (Mi), (F-FOMi).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; | 1992 |
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Car | 1992 |
A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
Topics: Adenocarcinoma; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchog | 1992 |
Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Dr | 1992 |
Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide | 1992 |
A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1991 |
Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Car | 1991 |
High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Non-S | 1991 |
A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1991 |
Phase III trial with and without lonidamine in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 1991 |
The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung. The Kyushu Lung Cancer Chemotherapy Study Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Tri | 1990 |
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
[Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
[Current results of chemotherapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
[Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide | 1990 |
High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell | 1990 |
[A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, N | 1986 |
[Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Carcinoma, Bronchogen | 1988 |
Bleomycin, vincristine, mitomycin and cisplatin alternated with cyclophosphamide, 4'-epidoxorubicin and procarbazine in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lu | 1988 |
A randomized clinical trial comparing systemic radiotherapy versus chemotherapy versus local radiotherapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyc | 1989 |
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clini | 1989 |
[A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1987 |
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cli | 1988 |
Treatment of advanced non-small cell lung cancer (NSCLC): the "Umbria" cooperative study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Eto | 1988 |
[Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Ca | 1985 |
Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Humans; Lung Ne | 1986 |
5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Admin | 1987 |
[Restorative effect of muroctasin, MDP-Lys (L 18), on leukopenia caused by anticancer chemotherapy in lung cancer--comparative study by envelope method].
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combin | 1988 |
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophos | 1986 |
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Clinical Trials as Topic; Fema | 1986 |
Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Clinical Trials as Topic | 1986 |
Differing response rates and survival between squamous and non-squamous non-small cell lung cancer. Comparison of CAP versus MAP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cy | 1986 |
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, S | 1985 |
338 other studies available for mitomycin and Cancer of Lung
| Article | Year |
|---|---|
In vitro cytotoxicity of the protoberberine-type alkaloids.
Topics: Animals; Antineoplastic Agents, Phytogenic; Berberine; Berberine Alkaloids; Brain Neoplasms; Breast | 2001 |
Synthesis, metal ion binding, and biological evaluation of new anticancer 2-(2'-hydroxyphenyl)benzoxazole analogs of UK-1.
Topics: Antineoplastic Agents; Benzoxazoles; Biological Products; Breast Neoplasms; Cell Line, Tumor; Cell S | 2008 |
Synthesis and docking studies of novel antitumor benzimidazoles.
Topics: Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, An | 2012 |
Transarterial chemoembolization for pulmonary or mediastinal metastases from hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2020 |
Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer.
Topics: A549 Cells; Antibodies, Neoplasm; Carcinoma, Non-Small-Cell Lung; Human Umbilical Vein Endothelial C | 2020 |
Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1-XPF-mediated DNA repair.
Topics: A549 Cells; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Computer S | 2021 |
CD73 and cN-II regulate the cellular response to chemotherapeutic and hypoxic stress in lung adenocarcinoma cells.
Topics: 5'-Nucleotidase; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; GPI-Lin | 2021 |
Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone | 2017 |
Transcatheter Arterial Chemoembolization with Spherical Embolic Agent in Patients with Pulmonary or Mediastinal Metastases from Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Chemoembolization, Therapeutic; Epirubicin; Fe | 2017 |
Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 2018 |
Isolated thoracic perfusion in lung metastases from breast cancer: a retrospective observational study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Che | 2019 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Carcinoma; Colorectal Neoplasms; Co | 2013 |
Histology as a potential clinical predictor of outcome in advanced non-small-cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C | 2013 |
ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform.
Topics: Anaphase; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Cytokinesis; DNA; DNA Rep | 2013 |
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carb | 2013 |
Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 2014 |
Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer.
Topics: Adult; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Ad | 2016 |
Comparison of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with mitomycin or carboplatin for diffuse malignant peritoneal mesothelioma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Female; | 2014 |
Safety of Brucea javanica and cantharidin combined with chemotherapy for treatment of NSCLC patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brucea; Cantharidin; | 2014 |
The transformation of a nonfunctioning islet cell tumor of the pancreas into a proinsulinoma under conditions of lung metastasis.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Is | 2015 |
Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells.
Topics: Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; C | 2015 |
Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent diffuse malignant peritoneal mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Cisplatin; Cohort Studies; C | 2015 |
Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the Heterogeneity.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Car | 2016 |
Prognostic implications of diffusion-weighted magnetic resonance imaging in patients with superior sulcus tumors receiving induction chemoradiation therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2016 |
Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells.
Topics: Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dose-R | 2016 |
Mitomycin C treatment induces resistance and enhanced migration via phosphorylated Akt in aggressive lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Drug Syn | 2016 |
Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response R | 2017 |
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Syne | 2008 |
Recurrent foreign body granuloma with airway obstruction: is there a role for steroids?
Topics: Airway Obstruction; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Dysp | 2008 |
Results of surgical treatment after neoadjuvant chemotherapy for stage III non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Co | 2008 |
Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Ca | 2009 |
Preoperative concomitant chemo-radiotherapy in superior sulcus tumour: A mono-institutional experience.
Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; | 2010 |
Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2009 |
Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small-cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Down-Regulation; Drug Synergism; Emodin; Humans; L | 2010 |
Re-challenge chemotherapy for relapsed non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Child; | 2010 |
[Therapeutic effects of vinorelbine-based chemotherapy--retrospective study of 65 patients with metastatic or relapsed breast cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2010 |
Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings.
Topics: Antibiotics, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Female; Follow-Up Stud | 2011 |
[Successful treatment of multiple pulmonary and peritoneal recurrence of hepatocellular carcinoma with bronchial artery infusion therapy and PEIT followed by surgery--a case report].
Topics: Aged, 80 and over; Antineoplastic Agents; Bronchial Arteries; Carcinoma, Hepatocellular; Ethanol; He | 2010 |
[Evaluation of the efficacy of bronchial arterial infusion chemotherapy for the treatment of central non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Car | 2011 |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Curcumin; Cytotoxins; Down-Regulation; Drug Synerg | 2011 |
ATR-p53 restricts homologous recombination in response to replicative stress but does not limit DNA interstrand crosslink repair in lung cancer cells.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Surviva | 2011 |
2A peptide-based, lentivirus-mediated anti-death receptor 5 chimeric antibody expression prevents tumor growth in nude mice.
Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Cell Death; Disease Models, Animal; Drug Synergi | 2012 |
Enhancement of mitomycin C-induced cytotoxicity by curcumin results from down-regulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Curcuma; Cur | 2012 |
Foxp3 overexpression decreases sensitivity to chemotherapy in mouse Lewis lung cancer cells.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell | 2012 |
Is there still a role for mitomycin-based combination chemotherapy in treating patients with nonsmall cell lung cancer? A single institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell | 2013 |
Detection of impaired homologous recombination repair in NSCLC cells and tissues.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; C | 2013 |
Induction chemotherapy before operation for multiple endobronchial squamous cell carcinoma of the lung.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineo | 2002 |
Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation.
Topics: Acute Disease; Aminopeptidases; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Ch | 2002 |
Neo-adjuvant chemotherapy in early stages of non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2002 |
[Clinical efficacy of the combination chemotherapy of high-dose epirubicin in non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 2001 |
[Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy | 2002 |
Treatment of interstitial peumopathy by fei tong oral liquid in the malignant tumor patients after radio- and/or chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Drugs, Chinese | 2003 |
Lung carcinoma with congenital plantar keratoderma as a variant of Clarke-Howel-Evans syndrome.
Topics: Adult; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Fatal Outcome; Fluorouracil; Hum | 2003 |
Differential relationship between changes in tumour size and microcirculatory functions induced by therapy with an antivascular drug and with cytotoxic drugs. implications for the evaluation of therapeutic efficacy of AC7700 (AVE8062).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Blood Flow Velocity; Cell Divisi | 2003 |
Ultralow doses of various drugs in chemotherapy of experimental tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Resp | 2003 |
[EXPERIENCE WITH PULMONARY CANCER ACCOMPANIED BY CHRONIC FEVER].
Topics: Fever; Freund's Adjuvant; Geriatrics; Lung; Lung Abscess; Lung Neoplasms; Lymphatic Metastasis; Mito | 1963 |
EARLY RESULTS OF COMBINED RADIATION AND CHEMOTHERAPY IN TREATMENT OF MALIGNANT TUMORS.
Topics: Antineoplastic Agents; Colonic Neoplasms; Dactinomycin; Fluorouracil; Humans; Lung Neoplasms; Mitomy | 1963 |
[METASTATIC LUNG TUMOR: CHARACTERISTICS OF THE X-RAY PICTURE AND THE TREATMENT OF CHOICE IN PRIMARY TUMORS].
Topics: Antineoplastic Agents; Humans; Lung Neoplasms; Mitomycin; Neoplasm Metastasis; Neoplasms; Pneumonect | 1964 |
TREATMENT OF MALIGNANT TUMOURS WITH 5-FLUOROURACIL IN 80 PATIENTS.
Topics: Biomedical Research; Breast Neoplasms; Colonic Neoplasms; Drug Therapy; Esophageal Neoplasms; Female | 1964 |
PROTRACTED AMBULATORY INFUSION CANCER CHEMOTHERAPY BY THE WATKINS CHRONOMETRIC INFUSOR.
Topics: Adenoma; Antineoplastic Agents; Breast Neoplasms; Carcinosarcoma; Colonic Neoplasms; Dermatitis, Exf | 1964 |
STUDIES ON CHEMOTHERAPY OF LUNG CANCER.
Topics: Antineoplastic Agents; Cyclophosphamide; Humans; Lung Neoplasms; Mitomycin; Mitomycins | 1964 |
[EXPERIMENTAL STUDIES ON THE EFFECT OF ANTI-CANCER CHEMOTHERAPEUTICS TO LIVER METASTASIS FOLLOWING PORTAL INJECTION OF MOUSE ASCITES HEPATOMA].
Topics: Animals; Ascites; Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Mice; Mitomycin; Mitom | 1963 |
[Roentgenological study of embryonal carcinoma of the testis metastatic to the lungs cured by mitomycin C].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Embryonal; Humans; Lung Neoplasms; Male; Mi | 1962 |
[Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2003 |
[Clinical benefit of bronchial arterial infusion chemotherapy to pulmonary metastasis from colorectal cancer--report of two cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Cisplatin; Colorectal Neoplasms; | 2003 |
Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Fluorouracil; Humans; Image Interpretation, Computer-A | 2003 |
Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and beta(1)-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitro.
Topics: Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phy | 2004 |
Hemodynamic variations during thoracic and abdominal stop-flow regional chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2004 |
P53-independent thermosensitization by mitomycin C in human non-small-cell lung cancer cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor | 2004 |
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; C | 2004 |
Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Lewis Lung; Cisplatin; C | 2004 |
Effect of change in cellular GSH levels on mitochondrial damage and cell viability loss due to mitomycin c in small cell lung cancer cells.
Topics: Antibiotics, Antineoplastic; Carcinoma, Small Cell; Caspase 3; Caspases; Cell Survival; Cytochromes | 2004 |
Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Line, Tumor; Disease P | 2004 |
Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-R | 2004 |
Treatment of unresectable lung metastases with transpulmonary chemoembolization: preliminary experience.
Topics: Adult; Aged; Aged, 80 and over; Chemoembolization, Therapeutic; Disease Progression; Female; Humans; | 2005 |
Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cardiac | 2005 |
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; | 2005 |
[Long-term survival in a case of large bowel cancer--efficacy of CPT-11-based chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Color | 2005 |
Is the tolerance to MIP chemotherapy different between English and other European populations?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III a | 2005 |
Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French trial database.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Databases | 2005 |
Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; I | 2005 |
[A case of advanced gastric cancer with liver and lung metastases markedly responded to TS-1-based sequential chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplasti | 2005 |
[Current data concerning neoadjuvant chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti | 2006 |
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carcinoma, La | 2006 |
Intrapericardial instillation of mitomycin C in recurrent cardiac tamponade due to malignant pericardial effusion.
Topics: Adenocarcinoma; Antineoplastic Agents; Cardiac Tamponade; Deoxycytidine; Fatal Outcome; Female; Gemc | 2006 |
[Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide | 2006 |
Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells.
Topics: Alternative Splicing; Cell Line, Tumor; Cisplatin; Fanconi Anemia; Fanconi Anemia Complementation Gr | 2006 |
[A case of non-small cell lung cancer in which complete response was achieved with chemotherapy including cisplatin, vinorelbine, mitomycin C, followed by additional cisplatin, etoposide and concurrent radiotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality | 2006 |
[A case of carcinomatous cardiac tamponade due to breast cancer treated with OK-432 and mitomycin C].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; | 2007 |
[Prolonged hypoxia induces GST-pi expression and drug resistance in lung adenocarcinoma cell line SPCA1].
Topics: Adenocarcinoma; Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Neoplasm; Epirubicin; Glutathione S | 2007 |
[Medical treatment for stage III non-small-cell lung cancer (NSCLC)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplat | 2007 |
[Chemotherapy of advanced non small cell lung cancer: effect on survival and symptoms affecting quality of life].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2007 |
Induction chemotherapy with cisplatin, vinorelbine, and mitomycin-C followed by surgery for patients with pathologic N2 non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2008 |
WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; beta-Galactosidase; Cell Prolife | 2008 |
Combination chemotherapy with mitomycin C, methotrexate, cisplatin, and vinblastine in the treatment of non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcino | 1984 |
Phase II trial of mitomycin-C in patients with small cell carcinoma of the lung after failure on combination chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 1984 |
[Chemotherapy against pulmonary metastasis from uterine cervical carcinoma].
Topics: Antineoplastic Agents; Carbazilquinone; Dextran Sulfate; Dextrans; Drug Therapy, Combination; Female | 1982 |
[Effects of the bronchial artery infusion of peplomycin (PEP) and mitomycin C (MMC) in lung cancer--comparison with single administration of PEP or MMC].
Topics: Antibiotics, Antineoplastic; Bleomycin; Bronchial Arteries; Drug Therapy, Combination; Humans; Infus | 1983 |
[Combination chemotherapy consisting of cis-platinum and adriamycin in non-small cell carcinoma of the lung].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1984 |
[Combined chemotherapy and elemental diet in advanced lung cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Proteins; Cisplatin; Doxorubicin; H | 1984 |
[Clinical study of combination chemotherapy with continuously infused peplomycin (PEP), cis-dichlorodiammineplatinum (II) (CDDP) and mitomycin C (MMC) (PPM therapy)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1983 |
[The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carbazilquinone; Carcinoe | 1984 |
[The clinical effect of hyperthermia combined with induced hypertension chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Pressure; Cisplatin | 1984 |
[Bronchial arterial cytostatic perfusion of bronchial cancer].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Bronchogenic; Doxorubicin; Female; Humans; Infusions, | 1984 |
Surgery and chemotherapy. A new method of treatment for squamous cell bronchial carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Bronchogenic; Car | 1984 |
[CDDP-containing combination chemotherapy for advanced lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1984 |
[Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Ce | 1984 |
[Platelet aggregation and coenzyme Q10 content in platelets in cancer patients].
Topics: Adult; Aged; beta-Thromboglobulin; Blood Platelets; Chromatography, High Pressure Liquid; Coenzymes; | 1984 |
Skin rash following therapy with mitomycin C.
Topics: Adenocarcinoma; Adult; Drug Eruptions; Humans; Lung Neoplasms; Male; Mitomycin; Mitomycins | 1984 |
Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Carcinoid Tumor; C | 1983 |
[Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1983 |
Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
Topics: Adenocarcinoma; Aged; Biological Products; Carcinoma, Small Cell; Drug Therapy, Combination; Female; | 1983 |
[Multidisciplinary treatment for small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclo | 1984 |
Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Br | 1984 |
Local erythema multiforme-like drug reaction following intravenous mitomycin C and 5-fluorouracil.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Drug Hypersensitivity; Erythema Multiforme | 1984 |
Bronchial artery infusion of mitomycin C in carcinoma of the lung.
Topics: Adenocarcinoma; Aged; Bronchial Arteries; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Female; | 1983 |
Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Topics: Adenocarcinoma; Adult; Aged; Biological Products; Cytotoxicity, Immunologic; Dactinomycin; Female; H | 1983 |
[Analysis of factors affecting clinical cancer chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Fluorouraci | 1983 |
[In vitro antitumor activity of 7-N-(p-hydroxyphenyl)-mitomycin C (KW-2083) against cultured bronchogenic carcinoma cells (PC-7)].
Topics: Carcinoma, Bronchogenic; Cell Line; Cells, Cultured; Drug Evaluation; Humans; Lung Neoplasms; Mitomy | 1983 |
[Serum levels of mitomycin C following a high-dose continuous hyperthermic peritoneal perfusion].
Topics: Female; Hot Temperature; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Ovarian Neoplasms; Perfusion | 1984 |
Feasibility study of combining metronidazole with chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Sq | 1983 |
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Drug Ev | 1983 |
Reversed-phase high-performance liquid chromatographic determination of mitomycin C in human serum.
Topics: Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Kinetics; Lung Neoplasms; Mit | 1984 |
Chemotherapy by bronchial arterial infusion for pulmonary metastases of renal cell carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Carbazilquinone; Doxorubicin; Female; Humans; Infusions, Intr | 1984 |
[Antitumor effect of new lymphokine OH-1 on BDF1 mice bearing Lewis lung carcinoma].
Topics: Animals; Cyclophosphamide; Doxorubicin; Female; Lung Neoplasms; Lymphokines; Mice; Mitomycin; Mitomy | 1984 |
[Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cell Line; Cyclophosphamid | 1984 |
Pharmacokinetics of mitomycin C in non-oat cell carcinoma of the lung.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chromatograp | 1984 |
Radiation and concurrent chemotherapy for the treatment of Lewis lung tumor and B16 melanoma tumor in C57/BL mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cesium Radioisotopes | 1984 |
Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative.
Topics: Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation, Preclinical; Drug Resistan | 1984 |
[A clinicopathological study on hematogenous recurrence of colo-rectal cancer--with special reference to prediction and prevention of the recurrence].
Topics: Antineoplastic Agents; Colonic Neoplasms; Combined Modality Therapy; Follow-Up Studies; Humans; Live | 1984 |
[Intracarotid arterial infusion with CDDP in combination with angiotensin II].
Topics: Adenocarcinoma, Papillary; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bra | 1984 |
Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin C.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Carcinoma, Bronchogeni | 1984 |
[Phase I-II study of 7-N-(P-hydroxyphenyl)-mitomycin C (KW2083, M83)].
Topics: Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Female; Hum | 1984 |
[Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anorexia; Antibiotics, Antineoplastic; Aspartate Amin | 1984 |
Phase I study of 7-N-(p-hydroxyphenyl)-mitomycin C.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Female; Humans; L | 1984 |
[Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Colonic Neoplasms; Female; Fever; Huma | 1984 |
Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems.
Topics: Animals; Carcinoma; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrosarcoma; Le | 1981 |
Drug activity and therapeutic synergism in cancer treatment.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration S | 1982 |
[Effects of administration of an antineoplastic agent into the bronchial artery].
Topics: Animals; Antineoplastic Agents; Bronchial Arteries; Carcinoma, Bronchogenic; Carcinoma, Brown-Pearce | 1982 |
[Renal cell carcinoma].
Topics: Adenocarcinoma; Cytarabine; Drug Therapy, Combination; Fluorouracil; Humans; Kidney Neoplasms; Lung | 1982 |
[Phase II study of KW2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with carcinoma of the lung and metastatic pulmonary tumor].
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Drug Evaluation; Femal | 1983 |
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemothe | 1993 |
Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; C | 1994 |
[Intra-arterial infusion chemotherapy for advanced liver metastases from lung cancer via implantable vascular access: report of six cases].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplat | 1995 |
[A case of lung cancer with choroidal metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Choroid | 1995 |
The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function.
Topics: Adult; Aged; Aged, 80 and over; Aging; Analysis of Variance; Antineoplastic Combined Chemotherapy Pr | 1995 |
Establishment and characterization of non-small cell lung cancer cell lines resistant to mitomycin C under aerobic conditions.
Topics: Aerobiosis; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dihydrolipoamide Dehydrogenase; D | 1995 |
Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion.
Topics: Adult; Aged; Combined Modality Therapy; Drainage; Female; Humans; Injections, Intralesional; Lung Ne | 1994 |
[In vitro drug sensitivity testing and chemotherapy of lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic | 1993 |
Lung cancer found in a patient with absence of the inferior vena cava associated with a left superior vena cava.
Topics: Aged; Angiography, Digital Subtraction; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, S | 1994 |
[Antitumor activity of LY 188011, a new deoxycytidine analog, against human cancers xenografted into nude mice].
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Colonic Neoplasms; Deoxycytidine; Drug Admini | 1994 |
Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2.
Topics: Animals; Antigens, Neoplasm; Female; Immunotherapy; Interleukin-2; Lung Neoplasms; Melanoma, Experim | 1994 |
Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
Topics: Aerobiosis; Animals; Antineoplastic Agents; Biotransformation; Carcinoma, Non-Small-Cell Lung; Cell | 1994 |
Tumor necrosis factor induces doxorubicin resistance to lung cancer cells in vitro.
Topics: Adenocarcinoma; Cell Cycle; Cisplatin; Cytokines; Doxorubicin; Drug Resistance; G1 Phase; Humans; Lu | 1994 |
Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Division; Cell Survival; Cisplatin; DNA, Neoplasm; Dru | 1993 |
[A case of advanced gastric cancer with liver and lung metastasis effectively treated by combined chemo-immunotherapy of MMC, 5'-DFUR, OK-432].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 1993 |
[A new cell line derived from a nude mouse resembling human large cell lung cancer].
Topics: Adult; Animals; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Gen | 1993 |
Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 1993 |
Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1993 |
[A case of bilateral pulmonary metastasis from rectal cancer successfully treated with resection after high-dose 5'-DFUR plus MMC combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Flox | 1993 |
[Alternative combination chemotherapy with mitomycin C, vincristine, methotrexate, 5-fluorouracil, cis-platinum and adriamycin for adenocarcinoma of the lung].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Do | 1993 |
[Experimental and clinical study in vitro chemosensitivity test for succinate dehydrogenase inhibition test].
Topics: Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neopla | 1993 |
Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2.
Topics: Animals; Antineoplastic Agents, Phytogenic; Base Sequence; Camptothecin; Cell Death; DNA Damage; DNA | 1993 |
Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs.
Topics: Amino Acid Sequence; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Dose-Re | 1993 |
Antitumor activity of treosulfan in human lung carcinomas.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti | 1996 |
Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia.
Topics: Antineoplastic Agents; Antioxidants; Biotransformation; Carcinoma, Non-Small-Cell Lung; Cell Divisio | 1996 |
[Possibilities of adoptive immunochemotherapy in the treatment of non-small-cell lung cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cyclophospham | 1996 |
[Chemohyperthermic peritoneal perfusion and high-dose chemotherapy followed by peripheral blood stem cell transplantation in advanced colon cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Combined | 1996 |
Histopathological grading of response to induction chemotherapy in non-small cell lung cancer: a preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, | 1996 |
Haemolytic uraemic syndrome in a patient with lung cancer: further evidence for a toxic interaction between mitomycin-C and tamoxifen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hemolytic-Uremic Syndrome; Humans; Lung Neop | 1996 |
A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-C | 1997 |
[Combined effect of adoptive immunotherapy (AIT) with lymphokine-activated killer (LAK) cells and interleukin-2 (IL-2) and chemotherapy in tumor-bearing mice].
Topics: Animals; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Immunotherapy, Adoptive; Inter | 1997 |
[Complete tumor regression obtained by chemoendocrine therapy including toremifene in two cases of pulmonary metastasis of breast cancer with a history of tamoxifen treatment].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; | 1997 |
Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells.
Topics: Adenocarcinoma; Animals; Cancer Vaccines; Female; Injections, Intraperitoneal; Injections, Intraveno | 1998 |
[Endoscopic findings of esophagitis in concurrent chemo-radiotherapy for lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 1998 |
Response of dermatomyositis co-existing with non-small cell lung cancer to chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dermatomy | 1998 |
[Three cases of colorectal cancer with lung metastasis successfully treated with combination chemotherapy using 5'-DFUR and MMC].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Sch | 1998 |
Efficacy of MGI 114 (6-hydroxymethylacylfulvene, HMAF) against the mdr1/gp170 metastatic MV522 lung carcinoma xenograft.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; H | 1998 |
Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small C | 1997 |
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1998 |
Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice.
Topics: Adenocarcinoma; Adipose Tissue; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood G | 1998 |
FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biotransformation; Body Weight; Carcinoma, Large Cel | 1998 |
[A case report: modified PMUE therapy might be effective for advanced gastric carcinoma with pulmonary carcinomatous lymphangitis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 1999 |
[Combination of 5'-DFUR and MMC for recurrent rectal cancer with pulmonary metastasis].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 1999 |
The effects of two different cisplatin-based chemotherapy regimens on advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Prediction of the chemosensitivity of lung cancer by 99mTc-hexakis-2-methoxyisobutyl isonitrile SPECT.
Topics: Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Etoposide; Fem | 1999 |
Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Cisplatin | 1999 |
[A long-term survivor of extensive-stage small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etopo | 2000 |
[Histoculture drug response assay on non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Camptothecin; Carcinoma, Non- | 2000 |
Tumor biology: use of tiled images in conjunction with measurements of cellular proliferation and death in response to drug treatments.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycl | 2000 |
[A case of large-cell lung cancer responding remarkably to combination chemotherapy with vinorelbine, mitomycin C and carboplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Drug Administrat | 2000 |
Chemotherapy for older people with non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Com | 2000 |
[Effectiveness of docetaxel plus cisplatin in large cell lung cancer showing little response to prior chemotherapy with MVP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Cisplatin; Docetaxel; Drug Ad | 2000 |
[Postoperative complications after radiochemotherapy or chemotherapy for bronchial cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Fistula; Carcinoma, Bronchoge | 2000 |
Validation of an orthotopic model of human lung cancer with regional and systemic metastases.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Carcinoma, Large Cell; Cisplatin; Disease Mode | 2001 |
[Surgical treatment of non-small cell lung cancer with mediastinal node invasion. A retrospective study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2001 |
Meta-analysis of single agents in the chemotherapy of NSCLC: what do we want to know?
Topics: Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cost-Benefit | 2001 |
Single-agent mitomycin for advanced non-small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; England; Female; Humans; L | 2001 |
Apoptosis and epithelial phagocytosis in mitomycin C-treated human pulmonary adenocarcinoma A549 cells.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Apoptosis; Cell Nucleus; Cytosol; Endoplasmic Reticulum | 2001 |
[Surgery and combined therapy for non-small cell lung cancer with invasion of the mediastinal nodes. A retrospective study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2001 |
[Treatment for elderly lung cancer patients by anticancer drugs and possible use of target based drugs].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Human | 2001 |
Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
Topics: Acute Disease; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic | 2001 |
[Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl | 2001 |
[Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2001 |
[A comparative study between clinical response and pathologic changes to preoperative chemotherapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
[Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
Mitomycin C, vinblastine and carboplatin: effective outpatient chemotherapy for advanced non-small cell carcinoma of the lung (NSCLC).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non | 2001 |
Managing poor performance non-small-cell lung cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; I | 2001 |
Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma.
Topics: Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Echocardiogr | 2002 |
Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Aziridines; Drug Resistance | 2002 |
[Evaluation of chemotherapy of unresectable non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru | 1992 |
Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Age Factors; Aged; Antineoplastic Combin | 1992 |
[Advances in the treatment of non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined | 1992 |
Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1992 |
Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Gene Expression; Humans; In Vitro Te | 1992 |
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1992 |
[Disappearance of lung metastases from hepatocellular carcinoma following bronchial arterial infusion of CDDP and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Hepatocellular; Cispl | 1992 |
[Experimental study on the effect of injection with anticancer agent-oil suspension].
Topics: Animals; Doxorubicin; Injections, Intralesional; Iodized Oil; Lung Neoplasms; Lymph Nodes; Lymphatic | 1992 |
Targeting cancer chemotherapy using a monoclonal antibody (NCC-LU-243) conjugated with mitomycin C.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Small Cell; Humans; Immunoglobulin G; Immunotoxins; Lung | 1992 |
Postoperative pulmonary toxicity associated with mitomycin-C therapy.
Topics: Adult; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Humans; Lung Neoplasms; Male; Mito | 1992 |
Pharmacokinetic study of mitomycin C with emphasis on the influence of aging.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; | 1992 |
Renal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1992 |
[A case of multiple pulmonary metastases from duodenal cancer showing partial response using 5'-DFUR and a small dose of MMC].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Duodenal Neoplasms; Female; Fl | 1992 |
Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1992 |
The role of three cisplatin-based chemotherapy regimens in the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lu | 1992 |
[Successful treatment of adenocarcinoma of the lung with bone metastases by combined chemotherapy with epirubicin, mitomycin C and carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubi | 1992 |
[Pharmacological study on Panax ginseng C. A. Meyer. XIV. Effect of 70% methanolic extract from red ginseng on the cytocidal effect of mitomycin c against rat ascites hepatoma AH 130].
Topics: Animals; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Chinese Herbal; Female; Liver Neop | 1992 |
[Psychological evaluation in chemotherapy of lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lung Neoplasms; Mal | 1992 |
[Experimental and clinical study of arterial damage induced by anti-cancer drug infusion].
Topics: Adrenal Cortex Hormones; Angiography; Animals; Arteries; Cisplatin; Doxorubicin; Endothelium, Vascul | 1992 |
[Intra-arterial infusion chemotherapy using implantable reservoir for liver metastasis of the lung cancer--an effective case].
Topics: Adenocarcinoma; Aged; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial | 1992 |
Combination therapy of radiation and Sizofiran (SPG) on the tumor growth and metastasis on squamous-cell carcinoma NR-S1 in syngeneic C3H/He mice.
Topics: Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Immunotherapy; Lung Neoplasms; Male; M | 1992 |
Mitomycin C, teniposide, and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality The | 1991 |
Necrotizing bronchial aspergillosis in a patient receiving neoadjuvant chemotherapy for non-small cell lung carcinoma.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus | 1991 |
[Assessment of a phase III trial of adjuvant chemotherapy in resected lung cancer: an imbalance of surgical results among cooperative institutions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical | 1991 |
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Eto | 1991 |
[Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1991 |
[A case of pulmonary metastasis from colon cancer responding completely to high-dose 5'-DFUR plus MMC combination chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic | 1991 |
[Pilot study of multi-cyclic combination chemotherapy in small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophospha | 1991 |
[The relation between myelotoxicity and performance status or aging in chemotherapy of non-small cell lung cancer].
Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcino | 1991 |
[Clinical evaluation of bronchial artery infusion (BAI) in lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Cisplatin; Female; Humans; Infus | 1991 |
[Pharmacokinetic approach to the improvement of clinical predictability in the preclinical test for antitumor agents].
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Survival; Doxorubicin; Drug Screening Assays, | 1991 |
Acute pulmonary failure with neoadjuvant protocol including mitomycin C and surgical therapy.
Topics: Acute Disease; Combined Modality Therapy; Humans; Lung; Lung Neoplasms; Mitomycin; Respiratory Insuf | 1991 |
[Incidence and clinical significance of the esophageal branches originating from the bronchial artery].
Topics: Bronchial Arteries; Esophagus; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Midd | 1990 |
Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherap | 1990 |
Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Drug Screening Assay | 1990 |
[Missile therapy of colorectal and pancreatic cancers--clinical trial of monoclonal antibody, A7-NCS, in 73 patients with colorectal and pancreatic cancers].
Topics: Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Colorectal Neoplasms; Doxorubicin; Drug A | 1990 |
Reappraisal of bronchial arterial infusion therapy for advanced lung cancer.
Topics: Adenocarcinoma; Adjuvants, Pharmaceutic; Aged; Carbazilquinone; Carcinoma, Small Cell; Carcinoma, Sq | 1990 |
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1990 |
[Interstitial pneumonia developed after combination chemotherapy with (CDDP, VDS, MMC) and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Mod | 1990 |
[A combined anti-emesis therapy of oral prednisolone and alprazolam for cisplatin-induced delayed emesis].
Topics: Administration, Oral; Adult; Aged; Alprazolam; Antineoplastic Combined Chemotherapy Protocols; Carci | 1990 |
[Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administration | 1990 |
Intracerebral choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; | 1990 |
[Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 1990 |
[Bronchial arterial infusion chemotherapy with or without radiotherapy for advanced lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Car | 1990 |
[Current perspectives in the management of non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Evaluation; | 1985 |
[Clinical study of chemotherapy (PPM therapy) with cisplatin, peplomycin and mitomycin C in squamous cell lung cancer].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcin | 1986 |
[Adjuvant therapy in resectable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Combined | 1986 |
[2 cases of "intrathoracic hyperthermia" as a new technic in the treatment of malignant pleural effusion].
Topics: Bleomycin; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Lung Neoplasms; Middle | 1987 |
[Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1988 |
[Bronchial arterial infusion chemotherapy (BAI) and BAI with radiotherapy in advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Arteries; Carcinoma, Non- | 1988 |
Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1989 |
Enhancement of chemical activation via radical-dependent mechanisms: an emerging concept in chemical-chemical interactions.
Topics: Animals; Bleomycin; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Chemical Phenomena; Chemistr | 1988 |
Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1989 |
Effect of artificial electron acceptors on the cytotoxicity of mitomycin C and doxorubicin in human lung tumor cells.
Topics: Carcinoma, Squamous Cell; Doxorubicin; Drug Interactions; Ellipticines; Humans; Lung Neoplasms; Meth | 1989 |
Concurrent radiation and chemotherapy in vulvar carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 1989 |
No difference between smoking lung cancer patients and smoking controls in the frequency of spontaneous and mitomycin C induced chromosome aberrations in lymphocytes.
Topics: Aged; Aged, 80 and over; Chromosome Aberrations; Humans; Lung Neoplasms; Lymphocytes; Male; Middle A | 1989 |
[A case of multiple pulmonary metastases from rectal cancer which responded completely to combination chemotherapy using 5'-DFUR and MMC].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Tolerance; Floxuridine; H | 1989 |
[Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1989 |
[Effect of the pulmonary artery infusion chemotherapy of non-small cel lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Hum | 1989 |
Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclo | 1989 |
[Combination chemotherapy with bronchial arterial infusion (BAI) and systemic chemotherapy in advanced non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Non-Small-Cell | 1989 |
[A case of recurrent hepatocellular carcinoma successfully treated by arterial chemoembolization in combination with local hyperthermia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality | 1989 |
Serial measurement of sister chromatid exchanges in the peripheral lymphocytes of patients with lung cancer receiving chemotherapy in relation to bone marrow toxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplat | 1989 |
[Pilot combination phase II study of mitomycin C plus cisplatin for non-small cell lung cancer].
Topics: Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm | 1989 |
[Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Ca | 1985 |
[Effects of bronchial artery infusion (B-AI) with single use of MMC after intravenous peplomycin (PEP) administration in lung cancer].
Topics: Adenocarcinoma; Bleomycin; Bronchial Arteries; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Huma | 1985 |
Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evalu | 1989 |
[MEP therapy of advanced lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyc | 1987 |
[Evaluation of combined chemotherapy including high-dose cisplatin in the treatment of malignant tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell L | 1987 |
Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1987 |
Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1987 |
Enhancement of differentiated type 2 cell function in the A549 cell line using mitomycin C1.
Topics: Adenocarcinoma; Cell Differentiation; Cell Division; Cell Line; Choline; Choline-Phosphate Cytidylyl | 1987 |
The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1988 |
The role of chemotherapy in non-small cell lung cancer: the community perspective.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1988 |
Neoadjuvant mitomycin C, cisplatin, and infusion vinblastine in locally and regionally advanced non-small cell lung cancer: problems and progress from the perspective of long-term follow-up.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; C | 1988 |
Simultaneous chemotherapy-radiotherapy with prophylactic cranial irradiation for inoperable adeno and large cell lung carcinoma: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcin | 1988 |
Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1988 |
Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1988 |
[State III large cell carcinoma of the lung cured by radiotherapy--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; | 1988 |
Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
Topics: Adenocarcinoma; Antigens, Differentiation, T-Lymphocyte; Carcinoma, Squamous Cell; Cell Separation; | 1988 |
[Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Availability; Capillary Perm | 1985 |
[Experience with induced hypertension chemotherapy for lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood P | 1985 |
[Effect of adriamycin, mitomycin-C, and tegafur (AMF) chemotherapy on advanced lung cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorub | 1985 |
[A case of adenoid cystic carcinoma in the paranasal sinuses with 8-year survival after pulmonary metastasis-- clinicopathological reference to 6 non-squamous cell carcinoma cases in the paranasal sinuses].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cyt | 1985 |
Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; C | 1985 |
Adenoid cystic carcinoma of the esophagus. Complete response to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Adenoid Cystic; Cisplati | 1986 |
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug | 1985 |
Neurologic dysfunction in patients treated for small cell carcinoma of the lung: a clinical and radiological study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Diseases; Brain Neoplasms; | 1986 |
[Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcino | 1986 |
[Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1986 |
[Phase II study of bronchial artery infusion of mitomycin C in non-small cell lung cancer].
Topics: Adult; Aged; Bronchial Arteries; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; In | 1986 |
[Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].
Topics: Carcinoma, Small Cell; Cells, Cultured; Colony-Forming Units Assay; Daunorubicin; Dose-Response Rela | 1987 |
[Chemotherapy of non-small cell bronchial cancer with mitomycin C, vindesine and cisplatin. Results of a phase II study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1987 |
[Treatment of non-small cell cancer of the lung with a combination of cisplatin-VP-16 and mitomycin C].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1987 |
[Microangiopathic hemolytic anemia (MAHA) and renal failure induced by anti-neoplastic agents--a case report].
Topics: Acute Kidney Injury; Aged; Anemia, Hemolytic; Antineoplastic Agents; Antineoplastic Combined Chemoth | 1987 |
5-Fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1987 |
A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinica | 1988 |
Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Colonic Neoplasms; Fluorouracil; Follow- | 1986 |
Combination chemotherapy for advanced colorectal cancer. A pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Female; F | 1986 |
Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Lomust | 1986 |
[Pharmacokinetics of mitomycin C (MMC) after infusion into the bronchial artery].
Topics: Aged; Bronchial Arteries; Humans; Infusions, Intra-Arterial; Kinetics; Lung Neoplasms; Male; Middle | 1986 |
Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids.
Topics: Female; Glucocorticoids; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomy | 1986 |
Preoperative treatment of squamous cell carcinoma of the lung with mitomycin-C in the bronchial artery.
Topics: Aged; Bronchial Arteries; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Infusions, In | 1986 |
[Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; | 1987 |
Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Azabicyclo Compounds; Carcinoma, Ehrlic | 1987 |
Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I major histocompatibility complex gene (H-2Ld).
Topics: Animals; Antibody Formation; H-2 Antigens; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mitomycin | 1987 |
[The pharmacokinetics of cisplatin and its influence on renal functions based on different infusion methods].
Topics: Acetylglucosaminidase; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Cisplat | 1987 |
Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
Topics: Adolescent; Adult; Aging; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Com | 1988 |
[Interstitial pneumonia after CMC (CDDP, MMC, CPM) therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined | 1988 |
[Antiemetic treatment with metoclopramide and high-dose lorazepam and additional long-term treatment with lorazepam during CDDP administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lorazepam; Lung Neoplasms | 1988 |
[Bronchial arterial infusion of lymphokine-activated killer cells stimulated by autologous tumor cells].
Topics: Bronchial Arteries; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Immunization, Passi | 1988 |
[Pulmonary manifestations of alveolar soft part sarcoma; bronchial arterial embolization for hemoptysis].
Topics: Adult; Bronchial Arteries; Combined Modality Therapy; Embolization, Therapeutic; Hemoptysis; Humans; | 1988 |
[Selective bronchial arteriography and infusion chemotherapy in patients with bronchogenic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Bronchog | 1988 |
[Intra-arterial drug infusion via the bronchial artery in the treatment of bronchogenic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Bronchog | 1988 |
Comparison of efficacy of mitomycin-C and corynebacterium parvum in the management of malignant pleural effusion.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Female; Humans; Immunotherapy; Lung Neoplasms; Male | 1988 |
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Body Wei | 1986 |
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Admin | 1986 |
Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic | 1985 |
Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytot | 1985 |
Effects of total-body hyperthermia on metastases from experimental mouse tumors.
Topics: Animals; Cisplatin; Hyperthermia, Induced; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, I | 1985 |
[Experimental studies on effects of total-body and local hyperthermia on metastases in mice].
Topics: Animals; Antibiotics, Antineoplastic; Body Temperature; Cisplatin; Combined Modality Therapy; Hypert | 1985 |
[Long-term results of the pulmonary resection with and without combined antineoplastic agents for primary bronchogenic carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carbazilquinone; Carcinoma, Bron | 1985 |
Cyclic combination chemotherapy in advanced adenocarcinoma of the lung: comparison of two FAM schedules.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fl | 1985 |
[In vitro drug-sensitivity test using human tumor clonogenic assay in lung cancer patients].
Topics: Aclarubicin; Antineoplastic Agents; Cell Count; Cell Division; Cells, Cultured; Cisplatin; Colony-Fo | 1985 |
Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dactinomycin; Doxorubicin; Glycoproteins; | 1985 |
Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Bronchog | 1985 |
Phase II evaluation of a combination of mitomycin C, vincristine, and cisplatin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Evaluation; Female; H | 1986 |
Phase II study of 7-N-(p-hydroxyphenyl)-mitomycin C (KW2083) in patients with advanced non-small cell carcinoma of the lung and metastatic pulmonary tumors.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomyci | 1985 |